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ABSTRACT
Topographical cues can profoundly affect cellular behaviors. This thesis investigate
how to utilize the topographical cues generated by two techniques, flow assembly and
electrospinning, to regulate cellular behaviors.
First of all, a facile and robust method to align one-dimensional (1D) nanoparticles
(NPs) in large scale has been developed. Using flow assembly, representative rod-like
nanoparticles, including tobacco mosaic virus (TMV), gold nanorods and bacteriophage
M13, have been aligned inside capillaries by controlling flow rate and substrate surface
properties. The properties of 1D NPs, such as stiffness and aspect ratio, play a critical role
in the alignment. Furthermore, these hierarchically organized structures can be used to
support cell growth, where cell orientation and morphology are controlled. When C2C12
myoblasts were cultured on surfaces coated with aligned TMV, we found that nanoscale
topographic features were critical to guide the cell orientation and myogenic
differentiation. This method can be used in the fabrication of complex assemblies with 1D
NPs and has wide applications in tissue engineering, sensing, electronics and optical fields.
Furthermore, we combined this flow assembly method with genetically modified
TMV mutants with reported cell adhesion sequences (i.e. RGD1, RGD7, PSHRN3, P15,
and DEGA) to generate biomimetic substrates with specific cell adhesion motifs and
precisely controlled structural organization for guiding cell behaviors by providing desired
biochemical and physical cues. We found that TMV mutants significantly promote neurite
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outgrowth and the resultant aligned TMV mutants substrates were able to dictate
directional neurite outgrowth of N2a cells. Hence, the plant virus-based materials provide
tremendous promise for neural tissue engineering in the future.
In addition, we generated the electrospun polycaprolactone (PCL) microfibers for
three dimensional (3D) culture of breast cancer cell lines, MCF-7. We found that cancer
stem cells (CSCs), a small group of tumor-initiating cells within tumors as the main
contributors of tumor growth, metastasis, and recurrence, have significantly increased the
proportion in the whole population. The expression of stem cell markers, including OCT3/4
and SOX2, and breast CSC-specific markers, SOX4 and CD49f, was significantly
upregulated, and the mammosphere-forming capability in cells cultured in 3D PCL
scaffolds increased. The fibrous scaffolds also induced the elongation of MCF-7 cells and
extended cell proliferation. The increase of CSC properties after culturing in 3D scaffolds
was further confirmed in the other two luminal-type mammary cell lines, T47D and SKBR-3, and a basal-type cell line, MDA-MB-231. Moreover, we observed the upregulation
of epithelial to mesenchymal transition and increased invasive capability in cells cultured
in 3D PCL scaffolds. These data suggests that the increase of CSC proportion in 3D culture
system may account for the enhanced malignancy. Therefore, our 3D PCL scaffolds can
potentially be used for CSCs enrichment and anti-cancer drug screening.
Finally, by electrospinning of polycaprolactone solutions containing N(benzoylthio)benzamide (NSHD1), a H2S donor, we fabricated fibrous scaffolds with
hydrogen sulfide (H2S) releasing capability (H2S-fibers). The resultant microfibers are
capable of releasing H2S upon immersion in aqueous solution containing biological thiols
under physiological conditions. The H2S release peaks of H2S-fibers appeared at 2~4 hours,
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while the peak of donor alone showed at 45 minutes. H2S release half-lives of H2S-fibers
were 10-20 times longer than that of donor alone. Furthermore, H2S-fibers can protect cells
from H2O2 induced oxidative damage by significantly decreasing the production of
intracellular reactive oxygen species (ROS). Given that H2S has a broad range of
physiological functions, H2S-fibers hold great potential for various biomedical applications.
In summary, the emerging area of nanotechnology have been applied for
biomedical application as well as the fundamental study of the interaction between cell
behaviors and surrounding nanomaterials. Here, we have generated a robust and facile
method that can align various 1D NPs in a large quantity. The resulting substrates in
capillaries can be used to guide the directionality of cell growth. Meanwhile, we
investigated the effects of electrospun microfibers on breast cancer stem cells and
fabricated H2S releasing fibers, which could be used in tissue engineering.
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CHAPTER 1
FACILE METHOD FOR LARGE SCALE ALIGNMENT OF ONE
DIMENSIONAL NANOPARTICLES AND CONTROL OVER
MYOTUBES ORIENTATION
Portions of this chapter appear in the following manuscript: facile method for large
scale alignment of one dimensional nanoparticles and control over myotubes orientation.1
1.1 INTRODUCTION
One-dimensional (1D) nanoparticles (NPs), such as nanorods, and nanotubes,
have become attractive building blocks for modern materials with wide applications in
tissue engineering,2 medicine,3 electronics,4 and optical devices.5 Due to their unique
anisotropic shapes and shape related properties of 1D NPs, the orientation and alignment
of 1D NPs is crucial for final material properties.6-7 For example, it has been shown that
both electrical and thermal conductivity of carbon nanotubes increases along the alignment
direction; and the enhancement was strongly dependent on the degree of alignment.8-9
Therefore, controlling 1D NPs orientation is an important topic during the development of
1D NPs materials.
A variety of methods have been proposed for integrating organized 1D NPs into
devices. One group of methods is based on the interaction between 1D NPs and supporting
substrates, where the orientation of 1D NPs is directed by surface chemical
functionalities,10 micropatterns fabricated by lithography,11 or the capillary force at a
contact line during a drying process.12 Another strategy to direct the orientation of 1D NPs
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is to employ an external force. This external force can be a contact shear force,13-15 electric
field,16 fluid flow,4, 17-18 or surface pressure.19 For example, using shear force generated by
fluid flow, Lieber and coworkers have demonstrated that indium phosphide, gallium
phosphide, and silicon nanowires were aligned by flowing nanowire suspensions through
polydimethylsiloxane templated microchannels.17 Inspired by the simple physics behind
this fluid flow method, we seek to expand it beyond the original microchannel setup, and
develop a cost-effective, time-saving, high-throughput and generally applied method to
control 1D NPs orientation in large scale.
Many cells or tissues with the aligned organization in vivo include neural cells20
corneal tissue,21 vascular tissue,22 musculoskeletal tissue23 and myocardial tissue.24
Directing cell orientation and differentiation is critical for tissue engineering in term of
mimicking the real tissue, in most of which the cell are directed by orientated extracellular
matrix (ECM) proteins.25,26 Taking advantage of 1D NPs to direct cell growth and
differentiation has been demonstrated by Werner, where aligned 1D collagen fiber
enhanced myotube organization and length, and modulated the growth and fate of
mesenchymal stem cells.27 In our previously studies, aligned bacteriophage M13 thin film
was utilized to guide cell oriented along the M13 aligned direction through directing the
secreted ECM protein.27,28 In addition, the confined spaces, perpendicularly to the capillary,
provided by tobacco mosaic virus (TMV) patterned rings were used to direct the
perpendicular orientation of smooth muscle cells to the capillary, which is believed to have
great potential to develop a vascular grafting.28
In this study, a facile and robust method to align one-dimensional (1D)
nanoparticles (NPs) in large scale has been developed. Using flow assembly, representative
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rod-like nanoparticles, including TMV, gold nanorods and bacteriophage M13, have been
aligned inside glass tubes by controlling flow rate and substrate surface properties (Figure
1.1a). TMV has the shape of a hollow cylinder (18 nm in diameter, 300 nm in length, and
4 nm cavity), consists of 2,130 identical subunits that assemble helically around single
strand RNA (Figure 1.1b and 1.1c) and can be modified chemically and genetically.30,31
The uniformly ordered nanostructure and well-defined geometry of TMV provides a
unique building block for nanomaterial development and biomedical applications.29-40
Therefore, TMV was chosen to optimize the experimental setup and assembly conditions.
When C2C12 myoblasts were cultured on surfaces coated with aligned TMV, we found
that nanoscale topographic features were critical to guide the cell orientation and myogenic
differentiation. This method can be used to fabricate complex structures with 1D
nanoparticles and will have wide applications in tissue engineering, sensing, electronics
and optical fields.
1.2 RESULTS AND DISCUSSION
1.2.1 Setup of the Flow Assembly for the Alignment of 1D NPs
The setup of the experiment is schematically illustrated in Figure 1.1a, which is
consisted of a glass capillary tube (inner diameter ~0.16 cm, length ~15 cm), a solution
feeder tube (plastic tubing with inner diameter ~0.15 cm) and high pressure gas cylinder
with a valve to control gas and subsequent fluid flow rate. One end of the plastic feeder
tube is connected to the glass capillary tube, and the other end is left open for filling 1D
NPs solution, and subsequent connection to a high pressure cylinder. All connection areas
are sealed to avoid the leaking of solution or gas. In this case, the NP solution is driven
through the glass capillary by the high pressure gas once the cylinder valve is open.
3
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Figure 1.1. Schematic illustration of flow assembly. (a) Schematic illustration of
experimental setup. One end of feeder tube is connected to the capillary while the other
end is kept open for filling of 1D NPs solutions and subsequent high pressure gas. 1D NPs
solution is only filled into the plastic tube, keeping the glass capillary tube empty. Then
the solution in the feeding tube is driven through the capillary tube by the high pressure
gas. After the NPs solution flows through the capillary tube, the capillary is dried by a
continuing gas flow. The arrow “→” indicates flow direction. (b) Transmission election
microscopy (TEM) image and (c) structure illustration of TMV. (d) AFM image of aligned
TMV on the inner surface of a capillary tube after the flow assembly, prepared with a TMV
concentration of 0.05 mg·mL-1 and a flow rate of 200cm·s-1. (e) Magnified image of (d).
(f) A histogram of TMV angular spread distribution with respect to flow direction.1
Before the fluid flow, the capillaries were immersed in chitosan solution (1
mg·mL-1 in 0.1% acetic acid at pH 6.5) for 20 mins, and then dried by the N2 flow. In a
typical experiment, 10 mL TMV (0.05 mg·mL-1) was filled into a plastic feeder tube and
driven through a capillary by a fluid flow rate of 200 cm·s-1, then dried completely with air
flow. TMV particles were distributed evenly with 96% surface coverage and an overall
alignment along the long axis of the capillary, as shown under AFM (Figure 1.1d and 1.1e).
More importantly, such alignment was observed on over 20 random positions in the inner
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surface of the glass tube, indicating a uniform coverage over the whole capillary tube. The
orientation of TMV was further quantitatively assessed by analyzing angles of more than
200 nanorods with respect to flow direction. The angular spread distribution histogram of
TMV is shown in Figure 1.1f. Over 84% TMV nanorods were aligned within ± 10°, and
the rest were distributed between ±10-30°. In addition, with this method, we also generated
the aligned TMV in the polycaprolactone (PCL) tubes (Figure 1.2), which is a widely used
material for tissue engineering. The coverage of TMV is lower in PCL tubes than glass
capillary tubes at the same prepared conditions, likely due to the difference of the surface
chemistry between PCL tubes and glass capillary tubes, which will be further discussed in
the next section.
1.2.2 Effects of Surface Properties on the TMV Alignment
In order to understand the origin of the aligned structure and key factors on
controlling the alignment, various control experiments were carried out. All samples and
their corresponding preparing conditions were listed in Table 1.1. All samples were
prepared under same TMV concentration (0.02 mg·mL-1) and flow rate (200 cm·s-1). After
the samples were ready, at least 20 AFM images were taken for each sample from the
random position of capillary tubes. Based on the AFM images, TMV angular spread
distribution histograms were obtained by analyzing the angles of more than 200 particles
with respect to the flow direction, then the histograms were simulated by Gaussian
equation. The alignment degrees of 1D NPs were also evaluated by the half-height peak
width (HPW), i.e. the peak width at the half-height of peak. The smaller the HPW number
is, the better alignment the sample has.17 The surface coverage was used to estimate the
coating efficacy of this method. The results are listed in Table 1.1. In the Control 1, the
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experiment was performed under the described condition, but no fluid flow was applied.
Only randomly distributed TMV (Figure 1.3a) with 44% surface coverage was observed.
The value of HPW is 176°, which is very close to the totally random distribution of 180°.
This result indicates that such aligned TMV nanorods structure was generated by the
shearing force from the solution flow.

40
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0
-60 -40 -20 0 0 20 40 60
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Figure 1.2. AFM image of aligned TMV on the inner surface of commercial PCL tube
after flow assembly, prepared with a TMV concentration of 0.02 mg·mL-1 and flow rate at
200cm·s-1. In brief, PCL tube with inner diameter ~1.8 mm was purchased from ColeParmer Company and was cut into 10 cm in length. Before fluid flow, the tube was treated
by immersing in 2 mg·mL-1 polyallyamine hydrochloride (PAH) solution (pH = 11.0)
overnight for aminolysis, and then washed by copious hydrogen chloride solution (pH = 2)
for 2 mins. Then (PSS/PAH)2 was coated on inner surface of PCL tube by following
procedure: alternatively immersing capillaries in PSS (1 mg·mL-1) for 20 min and PAH
solution (1.0 mg·mL-1 pH=5.0) for 20 min. Water was used to rinse in between each
deposition step until the desired number of layers was obtained. The (PSS/PAH)2 coated
tubes was used for the fluid flow assembly.1
The interaction between TMV and the substrate plays an important role on forming
this oriented structure. This interaction depends on two major factors: the surface energy
and the surface charge distribution. Because the pI of TMV is around 3.4,41 in our general
protocol, chitosan was used to give the capillary a positively charged internal surface. The
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water contact angle of chitosan coated surface was 48 ± 2. In Control 2 and 3, two other
cationic compounds, poly(diallyldimethylammonium chloride) (PDDA) and (3aminopropyl)triehoxysilane (APTES), were used to obtain similar positively charged
surface, but different surface energy. Simply judged from the water contact angles, Control
2 has higher while Control 3 has lower surface energy than chitosan modified surface
(water contact angles were 30 ±1 and 81 ±2, respectively). After the fluid flow, similar
assembly morphologies were obtained (Figure 1.3b) for both cases. Their comparable
HPW and surface coverage percent values with the typical sample (Table 1.1) indicate the
surface energy was not a key factor on controlling the alignment. On the other hand, if the
surface was negatively charged or neutral, as shown in Control 4-6, the high HPW were
generated (Table 1.1), suggesting TMV particles were randomly distributed (Figure 1.3c).
In addition, the surface coverage of Control 4-6 are much lower than the Control 2-3 and
typical chitosan modified samples (Table 1.1) due to electrostatic repulsion between TMV
and the substrate. These results revealed that the electrostatic interaction between TMV
and the substrate is critical for the formation of the aligned structure. To confirm this
hypothesis, we increased the ionic strength of the TMV solution by adding 50 mM
phosphate buffer (pH 7.0) to weaken the electrostatic attraction between TMV and chitosan
coated surface (Control 7). As our expectation, weakening attraction resulted in increased
HPW and decreased surface coverage (Table 1.1 and Figure 1.3d), indicating much less
TMV particles deposited and a worse alignment. Overall, the shearing force generated by
fluid flow can drag TMV particles to align along the flow direction, i.e. the long axis of
capillary tube, due to its anisotropic shape. The attractive force between TMV and capillary
internal surface plays an important role in pinning the TMV particles on the surface.
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Finally, we found that, once it was dried by following gas immediately, the
deposited TMV with aligned structure was almost no change on the HPW and slight
decrease in surface coverage after it was immersed into PBS solution at 37 C for 24h
(Figure 1.3f). This feature suggests that it is a relatively stable environment for the cell
study. However, TMV particles could be washed off if the sample was not dried completely
by the gas glow (Figure 1.3e), which gave a decreased surface coverage and a similar HPW
(Control 8 in Table 1.1).
(a)

HPW=176°

(b)

HPW=29°

(c)

HPW=170°

(d)

HPW=46°

(e)

HPW=30°

(f)

HPW=28°

Figure 1.3. Charge-charge interaction affects flow assembly. AFM images of (a) Control
1; (b) Control 2 (Control 3 gave similar results); (c) Control 4-6; (d) Control 7; (e) Control
8; and (f) The typical sample after immersed into PBS for overnight at 37 C. All scale
bars indicate 200 nm. The insets are the histograms of TMV angular distribution at
corresponding flow rates. The curve in each histogram is fitted by Gaussian equation based
on the histogram data. The angle distribution histograms were obtained by statistical
analysis of angular distribution of about 200 TMV particles with respect to the flow
direction.1
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1.2.3 Effect of Flow Rate on TMV Alignment
For testing the effect of flow shearing force on the alignment of TMV, different
flow rates ranging from 50 to 200 cm·s-1 were applied to prepare samples with fixed TMV
concentration at 0.02 mg·mL-1. Based on the AFM images (Figure 1.4a-d), TMV angular
spread distribution histograms were obtained by analyzing the angles of more than 200
particles with respect to the flow direction, then the histograms were simulated by Gaussian
equation (insets of Figure 1.4a-d). Obviously, with the increased flow rate, the width of
TMV angular distribution was narrowed, while the distribution near angle 0°in the
histograms increased. To evaluate the alignment degree of 1D NPs, the HPW was plotted
against flow rate and shown in Figure 1.4e. The HPW decreased from 52°to 28°with the
increased flow rate from 50 cm·s-1 to 200 cm·s-1. It implies that the alignment of TMV was
improved greatly by increasing the flow rate, which is consistent with the previous report.17
This phenomenon can be explained from the Newton shear flow theory: the shearing force
increases proportionally with the flow rate. Because the TMV particles are aligned in
response to the shearing force, a higher flow rate means a bigger shearing force, hence
leads to a better alignment. The best alignment in the experimental flow range for this
system is that about 84% TMV nanorods were aligned within ±10°at flow rate 200 cm·s1

. Thus the flow rate of 200 cm·s-1 was used for next samples preparation if it was not

mentioned specially. In all tested flow rate range, samples exhibited constant surface
coverage around 85%, as shown in Figure 1.4e. For testing the effect of flow shearing
force on the alignment of TMV, different flow rates ranging from 50 to 200 cm·s-1 were
applied to prepare samples with fixed TMV concentration at 0.02 mg·mL-1. Based on the
AFM images (Figure 1.4a-d), TMV angular spread distribution histograms were obtained
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by analyzing the angles of more than 200 particles with respect to the flow direction, then
the histograms were simulated by Gaussian equation (insets of Figure 1.4a-d). Obviously,
with the increased flow rate, the width of TMV angular distribution was narrowed, while
the distribution near angle 0°in the histograms increased. To evaluate the alignment degree
of 1D NPs, the HPW was plotted against flow rate and shown in Figure 1.4e. The HPW
(a)

HPW=52°
Surface coverage=82%

(b)

(d)

HPW=29°
Surface coverage=84%

(e)
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Figure 1.4. AFM images of flow assembly TMV on chitosan modified capillary tube at
different flow rates: (a) 50 cm·s-1; (b) 100 cm·s-1; (c) 150 cm·s-1; and (d) 175 cm·s-1. The
TMV concentrations were 0.02 mg·mL-1. The insets are the histograms of TMV angular
distribution at corresponding flow rates. The curve in each histogram was fitted by
Gaussian equation based on the histogram data. The angle distribution histograms were
obtained by statistical analysis of angular distribution of about 200 TMV particles with
respect to the flow direction. (e) The dependence of HPW direction on flow rate. All scale
bars indicate 200 nm.1
decreased from 52°to 28°with the increased flow rate from 50 cm·s-1 to 200 cm·s-1. It
implies that the alignment of TMV was improved greatly by increasing the flow rate, which
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is consistent with the previous report.16 This phenomenon can be explained from the
Newton shear flow theory: the shearing force increases proportionally with the flow rate.
Because the TMV particles are aligned in response to the shearing force, a higher flow rate
means a bigger shearing force, hence leads to a better alignment. The best alignment in the
experimental flow range for this system is that about 84% TMV nanorods were aligned
within ± 10°at flow rate 200 cm·s-1. Thus the flow rate of 200 cm·s-1 was used for next
samples preparation if it was not mentioned specially. In all tested flow rate range, samples
exhibited constant surface coverage around 85%, as shown in Figure 1.4e.
1.2.4 Influence of TMV Concentration on Alignment and Substrate Coverage
The surface coverage of the TMV can be controlled by the TMV concentration. As
shown in Figure 1.5a-c, the average coverage are about 95%, 86% and 50% for the TMV
concentration at 0.05, 0.02 and 0.005 mg·mL-1 respectively. In addition, the decreased
concentration also led to the slightly decreased alignment, as revealed by the HPW of the
simulated peaks (insets of Figure 1.5a-c). These results are consistent with previous
report.42 The differences in coverage in micro-scale as well as the alignment are important
for controlling cell orientation and differentiation, which will be further discussed in the
following cell study section.
1.2.5 Influence of 1D NPs Physical Properties on the Alignment
We extended our method to other 1D NPs and showed how the physical properties
affect the fluid flow assembly. A selection of different kinds of representative 1D NPs were
studied, including potato virus X (PVX),43 TMV-Aniline hybridized fibers,41 filamentous
bacteriophage M13,44 and gold nanorods (GNRs).45 The selection of these 1D NPs is due
to not only their representatives in their respective family, but also their distinctive physical
11

properties (aspect rations and rigidity). The preparation and purification of the selected 1D
NPs were described in detailed in the Experimental Section. The physical properties of
these 1D NPs are listed in Table 1.2 and TEM images are shown in Figure 1.6a-d.
(a)
(a)

HPW=26 0
Surface coverage=95%

(b) (b)

HPW=28 0
Surface coverage=86%

(c)

(c)

HPW=33 0
Surface coverage=50%

500 nm
500 nm

500 nm

500 nm

Figure 1.5. AFM images of flow assembly with different concentrations of TMV on
chitosan modified capillary tubes at a fixed flow rate of 200 cm·s-1: (a) 0.05 mg·mL-1; (b)
0.02 mg·mL-1; and (c) 0.005 mg·mL-1. The insets are their corresponding angular spread
distribution histograms of TMV with respect to the flow direction and HPW values.1
We fixed the flow rate at 200 cm·s-1and the 1D NPs concentration at 0.02 mg·mL-1
during the flow assembly process and the final results were observed by AFM (Figure 1.6eh). The particle alignment with respect to the fluid flow direction was analyzed, and
corresponding angular spread distribution histograms were obtained as shown in the insets
of the Figure 1.6e-h. The alignment degree was evaluated by the HPW, as plotted in Figure
1.6e. All of these 1D NPs showed the aligned orientation but with different degree. We
hypothesize that rigidity and aspect ratio of 1D NPs are two major factors on the alignment,
and 1D NPs with higher aspect ratio and higher rigidity can lead to a better alignment.
To study how the rigidity and aspect ratio affect the alignment, we set those 1D
NPs into several pairs for comparison, based on comparable rigidity or aspect ratio. The
role of rigidity on the alignment was illustrated by comparing alignment degrees of two 1D
NPs with similar aspect ratio, but different modulus, i.e. GNRs and TMV. The HPW of
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GNRs (14°) is much narrower angular spread than TMV (28°) because of the 45-fold
higher modulus of GNRs (Figure 1.6h versus Figure 1.1d), suggesting the higher rigidity
of 1D NPs result in the better alignment. The dependence of alignment on the aspect ratio
of 1D NPs could be reflected when compared two 1D NPs with similar modulus, but
different aspect ratio, e.g. TMV vs. TMV-Aniline fiber. The HPW of TMV-Aniline fiber
had been narrowed to 16°from 28°with the increased length from 300 nm to 4 mm (Figure
1.6f versus Figure 1.1d). Similarly, PVX, a little bit longer than TMV but with comparable
rigidity, showed a slightly better alignment degree (25°in HPW) than TMV (28°in HPW)
(Figure 1.6e versus Figure 1.1d). Furthermore, under comparable modulus, TMV, PVX
and TMV-Aniline fiber having gradually increased aspect ratio displayed the gradual
decrease in HPW. All of these results indicate higher aspect ratio of 1D NPs leads to a
higher alignment degree. Compared the HPW of TMV-Aniline fiber (16°) to M13 (44°),
much bigger difference between TMV-Aniline fiber and M13 than other pairs of 1D bioNPs was observed due to the synergetic enhancement from longer length and higher
modulus of TMV-Aniline fiber than M13 (Figure 1.6f versus Figure 1.6g). The surface
coverage is over 90% for all tested samples except the GNRs with 34% surface coverage
(Figure 1.6). The low coverage of the GNRs might be caused by its surface chemistry
defects.46
Finally, all tested 1D NPs had formed the aligned orientation. Among these 1D NPs,
TMV-Aniline fiber and GNRs have higher rigidities (Table 2.2), thus resulting in the best
alignment, i.e. 95% particles aligned within ± 10o and 98% aligned within ± 10o,
respectively, which may have potentials in the electronic and optic applications.47-48 The
rigidity and aspect ratio of the 1D NPs are two major factors on the alignment of the 1D
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NPs, which should be considered when this method is applied. The same method might be
used to control the alignment of other 1D NPs if optimized fluid flow and suitable attraction
between 1D NPs and substrate were applied
(a)

(c)

(b)

(e)

HPW=25 0
Surface coverage=91%

(f)

(h)

HPW=14 0
Surface coverage=34%

(i)

HPW=17 0
Surface coverage=93%

(d)

HPW=44 0
Surface coverage=98%

(g)

0

HPW ( )

40

30

20

TMV

PVX TMV-An
Fiber

M13

GNRs

Figure 1.6. Flow assembly of other 1D NPs. (a-d) are the TEM images of (a) PVX; (b)
TMV-Aniline fiber; (c) M13; and (d) gold nanorods (GNRs). (e-h) are the AFM images of
inner wall of capillary after flow assembly with (e) PVX; (f) TMV-Aniline fiber; (g) M13;
and (h) GNRs, with fixed flow rate of 200 cm·s-1and the concentration of 0.02 mg·mL-1 of
NPs. The capillary was modified by (PDDA/PAA)3 for (h), others are modified by
chitosan. The insets in (e-h) are their corresponding angular spread distribution histograms
with respect to the flow direction. Each histogram was obtained by statistical analysis of
angular distribution of about 200 nanorods. (i) The HPW plot of different 1D NPs. The
scale bars indicate 400 nm for all TEM images (a-d), 200 nm for (e), 500 nm for (f) and
(g), and 1 μm for (h).1
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1.2.6 Alignment and Differentiation of Myotubes
Enhancing the differentiation and alignment of cells in biomaterials is crucial for
engineering functional tissues with anisotropic properties.49 For example, in native
musculoskeletal tissue, the myoblasts form aligned fibers in a highly organized manner
through the fusion into the multi-nucleated myotubes.23 The similar organization with the
alignment also exists in myocardial tissue.24 This aligned arrangement is indispensable for
tissues to generate the contractile force. Using the aligned topographical features created
by flow assembly, we studied the orientation and differentiation of C2C12 myoblasts
guided by the contact cues.
Skeletal myogenesis, as a terminal differentiation process, is involved in the
differentiation and fusion of proliferating mono-nucleated myoblasts into multi-nucleated
myoblasts. C2C12 myoblasts have been used as a model system to study various types of
muscular dystrophies in vitro.50-52 Many studies have described the patterning of C2C12
cells on different modified surfaces. For instance, micro-contact printing has been used to
generate fibronectin islands with different geometric cues to study the C2C12 cells
alignment and maximize the differentiation.53 Previous study revealed a 2D substrate
coated with TMV or TMV mutants promotes rat bone marrow stromal cells osteogenic
differentiation.54 However, how the aligned TMV surfaces affect the alignment and
differentiation of C2C12 cells is still unknown. Four kinds of aligned TMV and TMVRGD-coated capillaries, TMVH, TMVL, RGDH and RGDL, were prepared for cell studies.
The letter H denotes high coverage (starting with 0.02 mg·mL-1 of TMV or TMV-RGD),
while L denotes low coverage (starting with 0.005 mg·mL-1 of TMV or TMV-RGD) of
TMV or TMV-RGD assembled on chitosan modified capillary tubes at a fixed flow rate of
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200 cm·s-1, and random arranged TMV coated capillary tubes were used as the control.
TMV-RGD here is the mutant TMV with inserted sequence GRGDSPG, and had been
proved to enhance cell attachment and stimulate osteogenic differentiation.30, 55
We first seeded C2C12 myoblasts in capillary tubes with different TMV alignments
and allowed cells to attach overnight. We did not observe any significant difference in the
cells attachment to substrates among different groups. After 3 day proliferation, cells were
subjected to differentiation medium (DM). Figure 1.7a shows the fluorescence images of
the cells with myosin heavy chain (MHC) (red) and DAPI (blue) staining on different
substrates after 7 days cultured in DM (representative images with low magnification are
shown in Figure 1.8). The appearance of MHC staining indicated the formation of the
myotubes in all groups.
In order to quantify the degree of the myotube alignment, using ImageJ software,
we measured the angles of myotubes with respect to the flow direction in 15 low
magnification fluorescence images in each group and plotted the angular distribution
histograms (Figure 1.7a). The TMVH showed the best alignment with HPW 34o; and the
RGDH and RGDL showed the moderate alignment. RGDH (HPW 46o) was a little higher
than RGDL (HPW 48o); and the TMVL displayed seldom alignment (HPW 126o), while
there was no alignment (HPW 180o) in the random TMV coated sample. Within the
deviation of ± 20 o, about 93% of myotubes were aligned for TMVH, and this number
decreased to 81%, 75%, and 49% for RGDH, RGDL and TMVL, respectively. The low
degree of the alignment in TMVL might be due to the low density of TMV is insufficient
to guide the C2C12 cells. However, the RGDL provides the strong binding motifs, RGD
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peptides, to C2C12 cells. By displaying the cell binding motifs, the low density of TMVRGD was still able to generate moderate guidance for the alignment of cells.

Figure 1.7. Alignment and differentiation of myotubes. (a) Fluorescent images of the
C2C12 cells with the induction of differentiation for 7 days on the tubes with different NPs.
Cells were stained for anti-MHC (red) and DAPI (blue). All scale bars indicate 100 μm.
The bottom rows are corresponding histograms of the angular distribution of myotubes. (b)
Quantification of the fusion index (b) and maturation index (c) for C2C12 cells in the tubes
with different NPs. They were calculated as the ratio of nuclei number in myocytes with 2
or more nuclei over the total nuclei number and the percentage of myocyte with 5 or more
nuclei, respectively. Significance: ** p < 0.01 and NS = not significant.1
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Figure 1.8. Fluorescent images of the C2C12 cells with the induction of differentiation for
7 days on the tubes with different NPs. Cells were stained for anti-MHC (red) and DAPI
(blue). All scale bars indicate 200 μm.1
To quantify the differentiation of myoblasts, we calculated the fusion index and
maturation index from the immunofluorescence images by determining the number of
nuclei from multinucleated myocytes over the number of total nuclei in that field and the
percentage of myotubes with 5 or more nuclei, respectively.56 Two independent
experiments were performed and 6 randomly images were used to determine the fusion
index and maturation index for each group. The results show that the fusion indices for
cells in TMVH and TMVL groups (66.1 ± 4.6% and 67.9 ± 2.6%, respectively)
significantly increased compared to the control group (54.1 ±3.4%) (p < 0.01). There is no
significant difference between TMVH and TMVL groups. In addition, the fusion indices
for cells in RGDH and RGDL (83.7 ± 4.4% and 80.2 ± 2.9%, respectively) are significant
higher than counterparts in TMVH, TMVL and control groups (p < 0.01). There is no
significant difference between RGDH and RGDL groups. Furthermore, the maturation
indices of cells in RGDH and RGDL groups (77.9 ± 2.6% and 80.0 ± 2.2%, respectively)
are statistically higher than TMVH, TMVL, and control groups (58.8 ±5.3%, 58.8 ±5.3%
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and 49.8 ± 5.9 %, respectively). Taken together, the myotubes in RGDH and RGDL had
the highest level of differentiation, which is consistent with previous report that RGD
peptide promotes the myotubes differentiation.57-59 Cells in TMVH and TMVL also
increased the level of differentiation compared to control groups.
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Figure 1.9. Immunofluorescent images of myoblasts (a-c), nuclei are DAPI-stained (blue),
and actin filaments are rhodamine-phalloidin stained (red). Angular spread of myoblast
actin filaments with respect to the flow direction is shown in (d-f). Un-aligned TMV as
control (a and d); high coverage aligned TMV (b and e); and low coverage aligned TMV
(c and f). All scale bars indicate 100 μm.1
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Previous study has observed that the alignment of myoblasts promote their
differentiation.60 The differentiation of myoblasts depends on two critical events: the
growth arrest

61

and the end-to-end contacts between myoblasts.62 In day 3, we observed

the C2C12 cells aligned along the orientation of TMV particles by F-actin staining (Figure
1.9). The alignment of myoblasts on capillary tubes with TMV particles may enhance
aligned end-to-end contacts between the cells. Therefore higher percentages of cells in
groups with aligned orientation were fused to differentiate into myotubes than control
groups.
1.3 CONCLUSIONS
In this work, we have demonstrated that the fluid flow assembly can serve as a
facile and robust method to align 1D NPs in large scale. The formation of thus aligned 1D
NPs was dominated by the shearing force generated by the fluid flow, interactions between
1D NPs and substrate, and the following drying process. In addition, the alignment degree
and coverage of the 1D NPs can be readily controlled by the flow rate, the concentration
and the nature properties (length and modulus) of the 1D NPs. In general, a better aligned
structure can be produced when longer and stiffer 1D NPs are used at higher flow rate and
higher concentration. This method has been used to align various kinds of 1D NPs,
including rod-like viral particles, hybridized conductive nanowires, and inorganic 1D NPs.
Capitalizing on the simplicity, flexibility and macro-scale of this method, this technique
can engineer aligned 1D NPs, with wide potential applications on tissue engineering,
electronic, and optical fields. Furthermore, compared to control group, the aligned virus
particles successfully guided myotubes alignment, and enhanced the myogenic
differentiation of myoblasts. In summary, we envision this method can be employed to
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mimic organized structures of the extracellular matrix (ECM), and can support and dictate
the cell growth, spreading and other responses, which is critical for many applications in
the emerging field of tissue engineering.
1.4 EXPERIMENTS
1.4.1 Materials
Poly(acrylic acid) (PAA) (MW 450000), poly(diallyldimethylammonium chloride)
(PDDA) (20 wt % in water, M~200 000-350 000 g/mol), poly(styrene sulfonate) (PSS)
(MW

70000

g/mol),

chitosan

(high

purity,

MW

60000-120000)

and

aminopropyltriethoxysilane (APTES) were purchased from Sigma-Aldrich; the materials
were used as received. Deionized water (18.2 MΩ.cm) used for rinsing and preparing all
the solutions was obtained from a Millipore Simplicity 185 purification unit. Serum media,
DMEM high glucose, was made by adding 6.7 g powder media (Hyclone, SH30003.03),
1.2 g sodium bicarbonate (Fisher Scientific , S233-500), 3.57 g HEPES (Cellgro, 61-034RM), 5.0 mL L-glutamine solution (Invitrogen, 25030081), and 5 mL penicillinstreptomycin (Invitrogen, 15140122) to 500 mL water (Millipore Synergy UV system, 18.2
MΩ.cm). The solution was then brought to pH 7.4 using 1 M sodium hydroxide solution
(J.T. Baker, E31H10). The media was sterilized by vacuum filtration using a low protein
binding media filter (Corning 0.22 µm, 431097). Then after filtration 50 mL fetal bovine
serum (FBS) was added (Atlanta Biologicals, S12450).
1.4.2 Purification of 1D NPs
The TMV, TMVRGD1 and PVX were harvested from the infected leaves according
to the reported methods.30-31 Briefly, 10 mM potassium phosphate buffer (pH 7.4) with
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0.2% -mercaptoethanol was added into crashed leaves, and centrifuged at 9000 rpm for
15 min. The supernatant was clarified with equal volume of CHCl3 and n-butanol (1:1
ratio). Toward the aqueous supernatant, 10% PEG800 and 0.2 M NaCl were added to
precipitate TMV. After the centrifugation, the pellets were resuspended in 10 mM
phosphate buffer. Finally, the pure viruses were obtained after the process of
ultracentrifugation for 2.5 h at 42 000 rpm (rotor Ti 75).
1.4.3 Filamentous Bacteriophage.
M13 was harvested from the infected E. coli according to previously reported
method.38,63 Briefly, 1 L of E. coli ER2738 culture was grown in LB-tet media to mid-log
phase and infected with 1 mL of wild type M13 bacteriophage (1012 PFU/mL). The
culture was incubated at 37 C with shaking for 5-6 h, centrifuged to remove bacterial
cells, the virus collected by PEG-NaCl (20% PEG and 2.5 mol·L-1 NaCl) precipitation
and reconstituted in Tris buffer.
1.4.4 Synthesis of TMV-Aniline Fibers
TMV-Aniline fibers was synthesized according to reported method.64 Briefly,
distilled aniline (10 L) and ammonium persulfate (10 mg·mL-1, 1 mL) were added to TMV
solution (1 mg·mL-1, 4 mL). The reaction was taken at room temperature for 24 h. The
reaction mixture was purified by dialysis for 5 h.
1.4.5 Synthesis of Gold Nanorods (GNRs)
GNRs was synthesized according to the seed-mediate growth method.45 The seed
solution is prepared as follows: the 0.6 mL ice-cold NaBH4 (10 mM) was added into the
mixture of CTAB solution (5 mL, 0.2 M) and HAuCl4 (5 mL, 0.5 mM); vigorous stirring
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of the seed solution for 3 minutes. The growth solution was prepared by mixing CTAB
solution (0.2 M) and HAuCl4 (0.5 mM) with same volume. The GNRs growth was
achieved by three steps: 1) 0.2 mL seeding solution was added into 2 mL growth solution,
which was transferred to 20 mL growth solution after 10 s; 2) after 30 s, the solution in
step 2 was poured into 200 mL growth solution; 3) the GNRs was synthesized by
incubating the solution at 25 C for 18h. The GNRs was purified by centrifuge with spin
speed 4000 rpm for 8 min. After re-dispersed into water, the GNRs were used for the
assembly.
1.4.6 Modifications of Capillary Tube
The polyelectrolyte coated capillaries were obtained by alternatively immersing
capillaries in PDDA (1 mg·mL-1) for 20 min and PSS or PAA solution (1.0 mg·mL-1) for
20 min, until (PDDA/PAA)3 or (PDDA/PSS)3 are obtained, where the value 3 indicates the
number of bilayers. Water was used to rinse in between each deposition step until the
desired number of layers was obtained. For chitosan modified capillaries: By immersing
into chitosan (1 mg·mL-1 in 0.1% acetic acid at pH=6.5), the chitosan coated capillaries
were obtained. The resulting samples were washed by water before using. The APTES
modified capillaries: Capillaries were immersed into 1% APTES in ethanol/water (95:5 by
volume) for 10 min and washed with pure ethanol three times, and dried with Nitrogen,
then incubated in vacuum at 120-130 C for one hour.
1.4.7 Flow Assembly of 1D NPs
Typically, 10 mL solution containing 1 D NPs was injected into the 1D NPs feeder
(Figure 1.1a), whose one end was connected to nitrogen tank and the other end was
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connected to capillary tube. The solution was driven through the capillary tube, and dried
by the following gas. The flow rate of solution was controlled by the gas pressure applied
to the flow.
1.4.8 Characterization of 1D NPs
A solution of 1D NPs was dropped on the glow-discharged Formvar-carbon coated
copper grid. After drying, the sample was negatively stained with 2% uranyl acetate for
TEM (Philips CM-12 transmission electron microscope at 80 kEV) observation. The
surface morphology was observed by AFM (SPA300, Seiko) in the tapping mode. The
angles of 1D NPs were measured with ImageJ software and then plotted in angular
distribution histograms. For M13, segments longer than 500 nm were measured for plot.
1.4.9 Cell Culture
The murine-derived muscle cell line, C2C12, was purchased from American Type
Culture Collection (ATCC, Manassas, VA). Cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM, #D6046, Sigma–Aldrich) supplemented with 10% heat
inactivated fetal bovine serum (Hyclone, Thermo Scientific), 100 U·mL-1 penicillin and
100 μg·mL-1 streptomycin (Gibco BRL, Invitrogen Corp., Carlsbad, CA, USA). C2C12 at
80-90% confluency were detached and re-suspend into culture medium in a concentration
of 2 ×106 cells per mL. The capillary tubes with TMV particles sucked the cell suspension.
After 5 hours, put the tubes with cells into the 12 well plates with culture medium. After
three days, the cells were shifted to differentiation medium (DM), which is DMEM
supplemented with 2% horse serum (Lonza Inc., Williamsport, PA). The medium was
replaced every other day. The time points in the figures indicate time after shifting to DM.
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1.4.10 Immunofluorescence Microscopy
Differentiated C2C12 cells were washed once with PBS and fixed with 4%
paraformaldehyde (Sigma-Aldrich, P6148) in PBS for 15 minutes. Cells were then blocked
with 5% goat serum and 0.3% TritonX100 for 60 min in PBS. The cells were incubated
with MF20 (anti-myosin heavy chain (MHC), Developmental Studies Hybridoma Bank
(DSHB), University of Iowa, IA) overnight at 4 °C and followed by ChromeoTM 642 Goat
anti-Mouse lgG (Active motif, Germany) and DAPI (Sigma, USA) in dark. Cells then were
imaged using an Olympus IX81 microscope. The images were analyzed with ImageJ
software. The images obtained from the MHC and DAPI signals were pseudo-colored red
and blue respectively.
1.4.11 Calculation of Fusion Index and Maturation Index
The fusion index was calculated by determining the ratio of nuclei number in
myocytes with two or more nuclei over the total number of nuclei. The maturation index
was the percentage of myotubes with five or more nuclei. Because the cells are in the
capillary tubes, cells on the edge were out of focus in images with low magnification. Cells
on the edge, which were out of focus, were not used for analysis.
1.4.12 Statistical Analysis
Statistical analysis for mean comparison was performed by using one-way analysis
of variance (ANOVA) Turkey’s test in OriginPro 8.5. All data values in this study were
reported as mean ±standard error of the mean.
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Table 1.1. Sample preparation conditions and results.
Results
Samples

Modification a

Surface
charge

Phosphate buffer
concentration
(mM)

Flow rate
( cm·s-1)

Washed
before
dryb

HPW ()c

Surface
coverage
(%)

Typical

Chitosan1

+

0

200

N

28 (Y)

96

Control 1

Chitosan1

+

0

0

N

176 (N)

44

Control 2

PDDA1

+

0

200

N

29 (Y)

88

Control 3

APTES1

+

0

200

N

29 (Y)

87

Control 4

(PDDA/PSS)3

-

0

200

N

170 (N)

5

Control 5

(PDDA/PAA)3

-

0

200

N

169 (N)

8

Control 6

Glass

Neutral

0

200

N

172 (N)

10

Control 7

Chitosan1

+

50

200

N

46 (N)

57

Control 8

Chitosan1

+

0

200

Y

30 (Y)

63

Note: a The subscript in this column noted as the modification cycle number; and the
modification methods are shown in experimental part. b The sample was washed by water
(Y) or not (N) before it was dried. c The aligned structure as Figure 1.1e can be obtained
(Y) or not (N).
Table 1.2. Parameters of different 1D NPs used in experiments.
1D NPs

TMV

PVX

TMV-Aniline
fiber

M13

GNRs

Contour length L (nm)

300

550

4, 000

880

350

Diameter (nm)

18

13.5

18.5

4.5

25

Aspect ratio

17

41

216

196

16

Persistent length P (mm)

~1, 00065

-

-

1.2766

-

Modulus (GPa)

1.167-68

0.8567

1.2366

0.6267-68

6469
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CHAPTER 2
FLOW ASSEMBLY OF TMV MUTANTS TO GUIDE DIRECTIONAL OUTGROWTH
OF NEURITES
2.1 INTRODUCTION
Tissue engineering provides a new therapeutic approach to regenerate or replace
damaged or diseased tissues with malfunctions by using biomaterials either with or without
living precursor cells.1 Thus, an ideal tissue engineering scaffold should bring to cells with
desired microenvironment that supports cellular growth and functions. The extracellular
matrix (ECM) play an important role in the microenvironment because cells are in direct
contact with ECM, which provides biochemical and mechanical cues to guide cellular
behavior and organization in vivo.2 Therefore, various biomaterials scaffolds, such as
electrospinning scaffolds,3 hydrogels,4 self-assembly of peptides,5 has been generated to
mimic the ECM. These biomaterials, that either resemble the nature structures of ECM or
possess biochemical compositions of ECM, may be useful in the tissue engineering field.
Recently, through chemical or genetic modification, viral particles have been used
to display various peptides.6 The resulting virus mutants have been extensively applied for
biomedical application, such as vaccine generation,7 stem cell differentiation,8 and drug
delivery.9 In particularly, tobacco mosaic virus (TMV) is a rodlike plant virus with a capsid
that is composed of 2130 identical copies of a protein monomer (coat protein, CP) and a
single-stranded 6.4 kb ribonucleotide. The intact capsid of TMV is 18 nm in diameter and
300 nm in length.10 By genetically fusing a cell binding motif to the surface exposed,
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carboxyl end of the CP, the virus particles displaying 2130 identical cell binding motifs
can be achieved. With this strategy, Lee et al. have generated TMV mutants displaying cell
binding motifs (i.e. RGD1, RGD7, PSHRN3, P15, and DEGA) and investigated their
effects on cellular morphologies and adhesion.11 Since a previous study indicated that ECM
derived peptides, such as RGD and PHSRN, could assist neural cells adhesion and promote
neurite outgrowth, we hypothesize that the TMV mutants bearing ECM derived peptides
can be used for neural tissue engineering.
Peripheral nerve injuries have caused much suffering every year. The most severe
injury is a complete nerve transection. Clinical treatments typically consist of either
directly end-to-end suturing the transected position (for small defects or gaps) or applying
an autologous/allogeneic nerve grafts (for longer nerve gaps).12 Although numerous FDA
approved guidance conduits have been applied to treat the peripheral neural injuries, the
effects of those materials are limited.13 A plausible explanation for the limited efficacy of
artificial nerve conduits is lack of physical guidance for the cells at a relevant nano-scale.14
Therefore, besides meeting the general requirement for biomaterials, such as being
biodegradable, permeable, and biocompatible, an ideal nerve conduit need to acquire the
feature of displaying biochemical cues and topographical cues for nerve regeneration
inside.
Numerous studies have shown that the nano or micro scale topographical feature
are of importance for cells to possess proper orientation and function.15-17 Previously, we
have developed a facile method for large scale alignment of one dimensional (1D)
nanoparticles in capillary tubes using external shear force. By doing so, various 1D
nanoparticles can be aligned homogeneously in the inner surface of capillaries and provide
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a topographical cues to guide cell orientation.18 Since this approach can be achieved in
biodegradable polymer capillaries, a potential application of this method is the fabrication
of nerve conduits.
This chapter presents our in vitro investigation of growing neural cells N2a on
substrates coated by TMV mutants with cell binding motifs. We demonstrated that the
TMV mutants are able to maintain cell viability, proliferation, and neurite outgrowth. By
aligning TMV mutants with shear force, we can achieve both homogeneously displaying
cell binding motifs and topographical cues in the inner surface of capillaries. The resulting
capillaries could be applied to guide directional neurite outgrowth of N2a in vitro.
2.2 RESULTS AND DISCUSSION
2.2.1 Cytocompatibility of TMV Mutants
Neural crest is a transient embryonic structure in vertebrates in which cells generate
most of the peripheral nervous system and several non-neural cell types.19 N2a cells is a
mouse neural crest-derived cell line that has been extensively used for studies of neural
differentiation,20 neurite outgrowth,21 and signaling pathway.22 Since we sought to apply
our newly generated materials in the repairmen of peripheral neural injuries, N2a cells are
used to verify the biological compatibility of various TMV mutants. Before the cell
experiments, various TMV mutants were isolated from tobacco leaves and characterized
by MALDI-TOF MS and TEM imaging prior use (Table 2.1 and Figure 2.1).
As with any biomaterial, a prerequisite task is to ensure they are non-toxic to the
target cells. To investigate the toxic effect of TMV-wildtype, and mutants including RGD1,
RGD7, P15, DGEA, and PHSRN3, were added to culture medium of N2a at various
concentration. Cell viability and proliferation were the measured with CellTiter Blue assay
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at day 1, 3, and 5 after TMV addition and compared to the population of cells cultured in
the same culture media without TMV (Figure 2.2a).

N2a cells grown in media

supplemented with RGD1-, RGD7-, PHSRN3-, P15-, DEGA-, and wildtype-TMV showed
similar number as the control at each of the concentrations and time points measured.
Moreover, as the positive control group, cells in TMV media showed significant
proliferation over the tested period (P < 0.001, two-way ANOVA with replication, n = 6).
Table 2.1. List of isolated TMV mutants
Virus

Insert Sequence

Calculated Mass (m/z)

Observed mass (m/z)

TMV-wt

N/A

17534

17533

TMV-RGD1

GRGDSPG

18161

18165

TMV-RGD7

AVTGRGDSPASS

18621

18622

TMV-DGEA

DGEA

17908

17950

TMV-PHSRN3

EDVRPHSRNSIT

18927

18957

TMV-P15

GTPGPQGIAGQRGVV

18910

18903

Figure 2.1. Characterizations of TMV mutants. (a) Direct detection of the coat protein
from crude plant sap by MALDI-TOF MS. TMV mutants were detected on various
positions regarding to their molecular weights. (b) Transmission electron microscopy
image of an isolated TMV mutant, TMV-RGD1. The scale bar indicates 500 nm.
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Figure 2.2. Biocompatibility of TMV materials. Cell viability and proliferation with TMV
exposure. (a) N2a cells exhibited similar cell numbers regardless of TMV addition to the
media at each of the tested time points. Cells exhibited significant proliferation (P < 0.001,
two-way ANOVA, n = 6) in the presence of each type of TMV mutants during the tested
time, same as the positive control (culture media without TMV). (b) N2a cells cultured on
various substrates coated by various TMV mutants exhibited similar proliferation rate,
same as the control cultured on tissue culture plastics (TCP) and PDL coating substrates
proliferation (* P < 0.001, two-way ANOVA , n = 6).
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2.2.2 Cell Proliferation and Differentiation on TMV mutants
To investigate whether the TMV mutants assist N2a cells adhesion, proliferation,
and differentiation, as the coating materials, we culture the N2a cells directly on top of
substrates coated with various TMV mutants and compare it to the behaviors of cells on
tissue culture plastics. Various virus particles were deposited on poly-D-lysine (PDL)
coated 12-well plates. In the PBS at pH 7.4, PDL plates carry positive charge on the surface,
where TMV bear negative charge on the surface. Thus, the electrostatic interaction between
PDL and TMV drive those virus particles tightly deposit on the surface of 12-well plates.
The presence of TMV particles on PDL coated surface was confirmed by atomic force
microscopy (AFM) and scanning electron microscopy (SEM) (Figure 2.3). The AFM
images suggested that the PDL coated surface were homogeneously and fully covered by
TMV particles and most of TMV particles maintain the natural rod-like morphology.
Previous study suggests that the resulting nano-scale topography of TMV substrates
promoted osteogenic differentiation of rat bone marrow stromal cells.23-24

Figure 2.3. Visualization of TMV coating on tissue culture plastics. (a) AFM image of
TMV coated tissue culture plastics. Scale bar represents 2 μm. (b) SEM image of TMV
coated tissue culture plastics. Scale bar represents 1 μm.
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With 2D substrates coated with various TMV particles in hand, we next investigate
whether those substrates carrying different cell binding motifs affect the proliferation of
N2a cells. When N2a cells were cultured on substrates coated with various TMV particles,
we did not observed significant morphological difference. In addition, the CellTiter Blue
assay was performed to determine cell proliferation on different substrates. As shown in
Figure 2.2b, cells N2a cells grown on substrates coated with RGD1-, RGD7-, PHSRN3-,
P15-, DGEA-, and wildtype-TMV showe similar number as the control at predetermined
time point. Furthermore, as cells cultured on tissue culture plastics and PDL coated tissue
culture plastics, cells on TMV substrates showed significant proliferation over the tested
period (P < 0.001, two-way ANOVA with replication, n = 6) (Figure 2.2b). This indicates
that the various cell binding motifs on TMV substrates did not affect N2a cells
proliferation.
It is well known that neuronal cells has the unique feature that they have the
tendency to aggregate and form the clusters when being cultured on unpleasant surfaces.25
Although, N2a cell, a neuroblastoma, is a cancerous cells, it also has this feature,
especially, when cells are confluent prior to their re-suspension.26 In order to determine the
efficacy of the TMV mutants as a neural tissue engineering material, we prepared
substrates with various TMV mutants, and characterized their effect on cell growth
patterns. To quantify the differences observed in the spatial distribution of cells on various
virus substrates, we used a nearest neighbor analysis, a method of analyzing spatial
relationship for a given population.27-28 The probability distribution function G(r),
represents the probability that a given cell will be located a certain distance r, away from
its neighbor. The distance between cells were determined by measuring the center
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coordinates of each cells represented in Figure 2.4. The control cell grown on tissue culture
plastics and cell grown on TMV wild type were very similar to clustered distribution. On
the contrary, cells grown on substrates coated with TMV mutants were more similar to the
theoretically independent distribution. A study by Merzlyak revealed that neural progenitor
cells grown on genetically modified M13 phages with cell binding motifs behaves similarly
to their counterparts cultured on laminin.28 Along with other previous works, these results
showed that the adhesion and spatial distribution of neural cells highly depend on the type
of cell binding ligands on surfaces.29
To determine the effect of being cultured on TMV mutants on neuronal
differentiation, we cultured N2a cells on various substrates with TMV mutants for 0-48
hours. In the presence of 10% serum, most N2a Cells were remained round undifferentiated
status. Most of N2a cells formed neurites after 48 hours being cultured in serum free
medium (Figure 2.5). We then quantified the length of neurites with Image J software, and
found that the cells cultured on TMV mutants with cell binding motifs significantly
increased neurites length compared to cells on TMV wild-type and PDL control group,
which are consistent with previous study that cell binding motifs promote neurite
outgrowth.29 One typical example is that RGD promote neurite outgrowth via interaction
with the αvβ3 integrin.30 Therefore, the TMV mutants with various cell binding motifs can
be used to enhance the extension of neurites.
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Figure 2.4. Growth patterns of differentiated N2a cells on TMV substrates. SEM images
of differentiated N2a cells (24 hours in differentiated media) on TCP (a) and wildtype- (b),
RGD1- (c), RGD7- (d), P15- (e), DGEA- (f), PHSRN3-TMV (g) substrates. (a-g) share the
scale bar in (g), indicating 100 μm. (h) Plot of cell spatial distribution on TMV substrates.
(i) Schematic diagrams of the nearest neighbor analysis.28 In the analysis the distribution
of cells can range from independent (represented by a theoretical Poisson’s distribution),
to clustered, or regular.
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Figure 2.5. Neurite outgrowth of N2a cells on TMV substrates. Images are typical fields
of differentiated N2a cells (48 hours in differentiation media) on PDL (a) and wildtype(b), RGD1- (c), RGD7- (d), P15- (e), DGEA- (f), PHSRN3-TMV (g) substrates. (a-g) share
the scale bar in (g), indicating 100 μm. (h) Average neurite length of cells in each group
(at least 200 cells were measured). Each data point is the mean ± SE of three independent
experiments. ** indicates P < 0.001.
2.2.3 Flow assembly of TMV mutants guide directional outgrowth of neurites
We have developed a robust and facile method for large scale alignment of one
dimensional (1D) nanoparticles (NPs), in which 1D NPs are aligned by an aqueous flow.
The resulting substrates with aligned TMV and TMV-RGD mutants promoted the
differentiation and orientation of myotubes generated by myoblasts (as shown in Chapter
1).18 Here, we applied this flow assembly method to align genetically modified TMV
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mutants with various cell binding motifs. We hypothesized the aligned TMV mutants could
induce the directional neurite outgrowth of N2a cells.

Figure 2.6. Flow assembly of TMV in capillaries in various densities. (a) SEM image of
control (i.e. 0.05 mg mL-1 TMV solution was slowly added in a capillary without applying
a fluid flow). SEM images of flow assembly of different concentrations of TMV on
chitosan modified capillary tubes at a fixed flow rate of 200 cm s-1: (b) 0.005 mg mL-1, (c)
0.01 mg mL-1, (d) 0.03 mg mL-1, (e) 0.05 mg mL-1, (f) 0.1 mg mL-1, and (g) 0.2 mg mL-1.
All SEM images share the scale bar in (g), indicating 500 nm. (h) The dependence of TMV
density on assembled solution concentration. Orientation order parameter for all conditions
remain above 0.85.

In order to test our hypothesis, we first proceed the flow assembly for TMV wild
type using TMV solution (0.005 – 0.2 mg ml-1). SEM images verified that TMV formed
the aligned orientation in the inner surface of glass capillaries after flow assembly, which
is consistent with previous report. The density of the TMV on the inner surface of the
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capillary kept increasing as the solution concentration increased, which has been
demonstrated by SEM images (Figure 2.6b-g). The orientation of TMV was further
1

quantitatively assessed by calculating the orientation order parameter (OP = 2 〈3 cos 2 𝜃 −
1〉). OP = 1 means perfectly orientated, and OP = 0 indicates randomly oriented system.
The orientation order parameters for each of condition ranged from 0.84 to 0.91 (Figure
2.6h). We then flow assembled other TMV mutants under same a solution concentration
(0.02 mg ml-1). The TMV particles were distributed evenly with above 85% surface
coverage and an overall alignment along the long axis of the capillary as shown by the
AFM images (Figure 2.7). The orientation order parameters for all TMV mutants were
between 0.85 and 0.90, indicating aligned nanoparticles were formed.

Figure 2.7. AFM images of flow assembly of TMV. (a) TMV, (b) RGD1, (c) RGD7, (d)
P15, (e) DGEA, and (f) PHSRN3 were flow assembled in capillaries. All images share the
scale bar in (f), indicating 2 μm.

Aligned organization of cells have been observed in various native tissues, such as
extracellular matrices,31 vascular epithelium,32 striated muscle cells,33 cardiomyocytes,34
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and neuron cells.35 Therefore, various techniques, such as mechanical loading,
topographical patterning, surface chemical treatment, and electrical stimulation, have been
utilized for engineering cells to form aligned organization in tissue engineering.17 Previous
study suggests the topographical cues with desired scale are crucial for nerve regeneration.
In order to test our designed capillaries with aligned viruses as a guidance for neurites
outgrowth, we seeded N2a cells into the capillaries with aligned viruses. After switch to
differentiation media, N2a cells in the capillaries with aligned TMV were able to
differentiate and extend neurites in a direction parallel to the long axis of the capillary,
which is the flow direction (Figure 2.9b-g and Figure 2.8). The orientation order parameters
of neurites for cells on TMV, RGD1, RGD7, P15, DGEA, and PHSRN3 were 0.62, 0.56,
0.45, 0.46, 0.61 and 0.52, respectively (Figure 2.8h). In contrast, the cells on control group,
which is absent of NPs, did not show preferred orientation and has an OP = 0.28 (Figure
2.9a and 2.9h). These results indicates that the aligned TMV mutants guided the neurites
directional outgrowth and also provide chemical signal to promote neurite extension.

Figure 2.8. N2a cells growth in capillaries with aligned TMV mutants. N2a cells generated
neurites in capillaries with flow assembled aligned TMV particles of (b) TMV-wildtype,
(c) RGD1, (d) RGD7, (f) P15, (g) DGEA, and (h) PHSRN3. (a) Control group that cells
were cultured in capillary without TMV. (e) Cells were cultured on tissue culture plastics.
All images share the scale bar in (h), indicating 200 μm.
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Figure 2.9. Orientation of neurite outgrowth on aligned TMV substrates. Wind rose plot
of the neurite orientations on control (no virus) (a) and wildtype- (b), RGD1- (c), RGD7(d), P15- (e), DGEA- (f), and PHSRN3-TMV (g) substrates. (h) Analysis of neurite
alignment using the orientation order parameter (scale from 0 for no alignment to 1 for
complete alignment). Each data point is the mean ± SE of three independent experiments.
** indicates P < 0.001.
2.3 CONCLUSIONS
In tissue engineering, understanding the cell-materials interaction is critical for
developing specific cell-materials interfaces to control over cellular behaviors. In this
chapter, we have tested five genetically modified TMV mutants that carry cell binding
motifs of RGD1, RGD7, P15, DGEA, and PHSRN3, for their ability to support neural cells
growth and differentiation. The virus particles were non-toxic towards neural cells. In
addition, TMV mutants with cell binding motifs significantly improve neurites outgrowth
of neural cells compared to TMV wild type and poly-D-lysine coating control.
Furthermore, the aligned TMV and TMV mutants by flow assembly provide specific
nanotopographical cues to guide directional neurite outgrowth. Given this method can be
applied in biodegradable polymer capillaries to provide desired topographical guidance to
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neural cells, we anticipate the combination of plant virus particles and flow assembly
method might provide better nerve conduit for the repair of nerve injuries.
2.4 EXPERIMENTS
2.4.1 Cell Culture
N2a neuroblastoma cells is obtained from American cell type culture collection.
Briefly, N2a cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM,
#D6046, Sigma–Aldrich) supplemented with 10% heat inactivated fetal bovine serum
(Hyclone, Thermo Scientific), 100 U mL-1 penicillin and 100 μg mL-1 streptomycin (Gibco
BRL, Invitrogen Corp., Carlsbad, CA, USA) in presence of 5% CO2 at 37C.
2.4.2 Purification of TMV
The TMV, TMV-RGD1, TMV-RGD7, TMV-P15, TMV-DGEA and TMVPHSRN3 were isolated from the infected leaves according to the reported methods.11
Briefly, 10 mM potassium phosphate buffer (pH 7.4) with 0.2% -mercaptoethanol was
added into crashed leaves, and centrifuged at 9000 rpm for 15 min. The supernatant was
clarified with equal volume of CHCl3 and n-butanol (1:1 ratio). 10% PEG800 and 0.2 M
NaCl were added to the aqueous supernatant to precipitate TMV. After the centrifugation,
the pellets were resuspended in 10 mM phosphate buffer. Finally, the pure viruses were
obtained after the process of ultracentrifugation for 2.5 h at 42 000 rpm (rotor Ti 75).
2.4.3 Cytotoxicity of Viruses to N2a Cells
Various concentrations (from 10-1 to 10-3 mg mL-1) of genetically modified TMV
mutants (displaying RGD1, RGD7, P15, DGEA, and PHSRN3) and wild-type TMV were
added to the media. Given that the footprint of the TMV were a 18nm wide and 300 nm
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long rectangle, we calculated that each well (0.34 cm2 surface area) of the 96-well plates
used for viability assays could be completely covered by approximately 6 ×109 TMV. This
quantity of virus was used to set a median TMV concentration of 10-2 mg ml-1, and TMV
concentrations that were 10 times greater and 10 times less were tested to determine
whether the TMV mutants affected cellular viability. The culture medium containing
constant TMV concentration were changed daily for each group. Cell viability was
determined by CellTiter-BlueTM Cell Viability Assay (Promega, Madison, WI) at
predetermined time points.
2.4.4 Preparation of Cell Culture Substrates

All surfaces used for culturing N2a cells were pre-coated before cell plating. 0.7 ml
viruses in aqueous solution (1 mg mL-1) were dropped into 12 well plates that were coated
with Poly-d-Lysine using protocol suggested by Corning®. The virus solutions were
incubated with the PDL coated plate in sterile cells culture hood for overnight. Then each
well was rinsed briefly with 18.2 mΩ water before used for N2a culture.
2.4.5 Surface Characterization of Virus Based Substrates by AFM
The surface morphology of virus based scaffolds was observed by AFM
(Nanoscope IIIA MultiMode AFM (Veeco)). The bottoms of each 12 well plate were cut
out after virus coating and rinsed with 18.2 mΩ water then dried with a stream of nitrogen
gas before mounted onto AFM sample holder for imaging in the tapping mode.
2.4.6 Nearest Neighbor Analysis
Spatial distribution analysis of the cells on various genetically engineered TMV
and control surfaces was performed by using ImageJ and R software packages. The images
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of cell were initially processed with ImageJ to be represented by particles, and their
centroid coordinates were determined. This data was then imported into R for nearest
neighbor analysis using the SpatStat module.36
2.4.7 Quantification of Neurite Outgrowth
To quantify the length of the neurite outgrowth, we stained cells using crystal violet.
Briefly, cells cultured on various TMV substrates and control were induced to
differentiation by low serum culture medium (1% FBS). Cells were washed in PBS, fixed
with ice-cold methanol at -20C for 15 min. and then stained with 0.5% crystal violet
solution in methanol for 30 min at room temperature. Using an inverted light microscope,
we took the images and quantified the length of neurites by ImageJ. Five random fields
were examined from each well, giving a total cell count of at least 200 cells per well. Each
data point represents the mean of three independent experiments.
2.4.8 Flow Assembly of TMV
Flow assembly of various viruses for cell culture were performed as previously
described.18 Briefly, the chitosan coated capillaries were obtained by immersing into
chitosan (1 mg·mL-1 in 0.1% acetic acid at pH=6.5). Water was used to wash before using.
10 mL solution containing 1 D NPs was injected into the 1D NPs feeder, which one end
was connected to nitrogen tank and the other end was connected to capillary tube. The
solution was driven through the capillary tube, and dried by the following gas. The flow
rate of solution was controlled by the gas pressure applied to the flow.
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2.4.9 Characterization of TMV and TMV Coated Substrates
TMV solution was dropped on the glow-discharged Formvar-carbon coated copper
grid. After drying, the sample was negatively stained with 2% uranyl acetate for TEM
(Philips CM-12 transmission electron microscope at 80 kEV) observation. The surface
morphology was observed by AFM (SPA300, Seiko) in the tapping mode. The angles of
1D NPs were measured with ImageJ software and then calculated for the orientation order
1

parameter (OP = 2 〈3 cos 2 𝜃 − 1〉).
2.4.10 Directional Neurite Outgrowth in Capillaries with TMV
N2a cells were trypsinized and then seeded in the capillaries with aligned viruses.
After 24 hours, cells were switched into differentiation medium. After 48 hours
differentiation, samples were observed under microscopy. The angles of neurites were
measured with ImageJ software and angular distribution were then plotted in a circular
1

histogram and calculated for the orientation order parameter (OP = 2 〈3 cos 2 𝜃 − 1〉). For
each of the group, at least 300 neurites were measured from three independent experiments.
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CHAPTER 3
EXPANSION OF BREAST CANCER STEM CELLS WITH FIBROUS SCAFFOLDS
Portions of this chapter appear in the following manuscript: expansion of breast
cancer stem cells with fibrous scaffolds.1
3.1 INTRODUCTION
Cells cultured in vitro two dimensional (2D) tissue culture plastics (TCP) lack of
the structural architecture necessary for proper cell-cell and cell-matrix interactions that
exists in vivo.2-4 The complexity of the in vivo system, being composed of many
uncontrollable factors, such as immune response, endogenous growth factors,
hemodynamics and mechanical cues, complicates researches on effects of individual factor
on cell behaviours. On the other hand, although rodent animal models are relative reliable
system for human cancer research and have been used for several decades,5-8 the significant
difference in telomerase regulation between humans and rodents makes transgenic and
inducible mouse cancer model questionable in term of replicating the human cancers.9
Hence, three-dimensional (3D) cell culture models emerged to bridge the gap between in
vivo human cancer studies and in vitro 2D cell culture models, as well as animal models.
The fabrications of 3D scaffolds for the study of tumor cells in vitro have adopted
techniques from developed fields of tissue engineering.2, 10-11 Among those techniques, the
electrospinning process is a simple and rapid method to generate scaffolds with fibers range
from micrometer to nanometer in diameter.12 Although cells in electrospun fibrous
scaffolds often adhere on the surface with minimum penetration, researchers consider these
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scaffolds as a 3D-like culture system because cells are able to acquire the nutrition and
extracellular signal three dimensionally.13 Among various natural and synthetic polymers
available for electrospinning process, poly(ε-caprolactone) (PCL) have attracted interests
of researchers due to low melting temperature, good blend-compatibility, FDA approval,
and low cost.14 Nano and micro scale fibrous scaffolds by electrospinning are ideal for 3D
cells culture, because their structures are similar to components in extracellular matrix,
providing essential cues for cellular survival, proliferation, organization, and function.13
Tumor cells grown in 3D scaffolds tend to develop the morphologies and
phenotypes observed in vivo15-17 and displayed higher invasive capability, and increased
drug resistance relative to cells in a 2D culture condition.18-19 However, the mechanism of
those alterations is still unclear. Recent researches revealed extracellular matrix (ECM)
proteins can be either coated in 2D dishes or fabricate into 3D scaffolds for the
enhancement and maintenance of the stemness properties of cancer cells.20-21
Cancer stem cells (CSCs) are rare subpopulations that have the capability to initiate
tumor growth. Recent researches reveal that CSCs are responsible for metastasis,22 chemoresistance,23 and radio-resistance.24 In the present study, we hypothesized that the
electrospun PCL fibrous scaffolds itself without any protein component can increase CSCs
population. Using aldehyde dehydrogenase (ALDH) activity as a CSCs marker25 and
mammosphere formation assay,26 we found that MCF-7, T47D, SK-BR-3 and MDA-MB231 cells cultured in electrospun PCL fibrous scaffolds increased the CSCs population. The
enhanced invasiveness and upregulation of epithelial-to-mesenchymal transition (EMT)
markers indicates cells were undergoing EMT, which might trigger the transformation of
non-stem cancer cells to CSCs.27
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3.2 RESULTS AND DISCUSSION
3.2.1 Fabrication of Electrospun PCL Fibrous Scaffolds
PCL fibrous scaffolds were fabricated using a home-made electrospinning
apparatus. For electrospun scaffolds to be reproduced, the important parameters of
electrospinning were recorded and illustrated (Figure 3.1a). With a stationary collector
placed at 10 cm underneath the tip, random fibrous scaffolds were obtained, and no
preferred fiber orientation was observed under scanning electron microscope (SEM)
(Figure 3.1b). The average fiber diameter calculated by Image J software was 1.63 ± 0.36
μm and the diameter distribution of this PCL scaffolds ranged from 0.76 to 2.35 μm (Figure
3.1c).

Figure 3.1. PCL fibrous scaffolds were fabricated by the electrospinning process. (a) The
electrospinning setup was illustrated schematically. (b) The SEM image of the electrospun
PCL fibrous scaffold. Scale bar indicates 100 μm. (c) The distribution of the fiber diameter
on PCL fibrous scaffolds fabricated in the described setting.
Although in diseases or during the movement, the ECM will be reorganized in
aligned orientation, the major component of ECM, collagen fibers, usually randomly
surrounded the breast epithelial cells,28 which is similar to the organization of the
electrospun PCL random fibrous scaffolds. Our lab found that luminal-type cell line MCF7 maintained cell-cell contact and random orientation on aligned fibrous scaffolds,
indicating less impacts of the aligned fibers on the cells.29 The aligned fiber orientation will
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introduce the mechanical stretch on the cells, which might complicate the interpretation of
results. Therefore, in this study we use random orientation fibrous scaffolds for cell culture.
3.2.2 Cellular Morphology and Growth on Electrospun PCL 3D Scaffolds
MCF-7 cells successfully propagated on PCL fibrous scaffolds. Fluorescence
microscopy revealed different morphologies between MCF-7 cells cultured on electrospun
PCL fibrous scaffolds and TCP (Figure 3.2). Cells on TCP exhibited trigonal or polygonal
morphologies, whereas cells on PCL fibrous scaffolds showed round shuttle-like shape.
We also observed similar results in T47D, SK-BR-3, and MDA-MB-231 cells (Figure 3.3).
Relative to cells on TCP with a spreading-out morphology, cells on PCL fibrous scaffolds
displayed smaller F-actin staining area and round-like shape. This is might be due to that
fibers surrounding cells limited cells spreading and cells increased the thickness (Figure
3.4).

Figure 3.2. Fluorescence microscopy images of MCF-7 cells cultured in 2D tissue culture
plastics. (a-c) and 3D PCL fibrous scaffolds (d-f). Blue indicates nuclei (DAPI); red
indicates F-actin (Rhodamine-Phalloidin). All scale bars indicate 100 μm.
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Figure 3.3. Fluorescence microscopy images of T47D, SK-BR-3, and MDA-MB-231 cells
cultured in 2D tissue culture plastics and 3D PCL fibrous scaffolds . Blue indicates nuclei
(DAPI); red indicates F-actin (Rhodamine-Phalloidin). All scale bars indicate 100 μm.
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Figure 3.4. MCF-7 cells seeded in PCL fibrous scaffold occupied architectural features of
the matrix in three dimensions as observed using confocal microscope. 3D reconstruction
of sequential strata demonstrated MCF-7 occupation of sub-surface niches within the PCL
scaffold. Serial z-plane sampling was conducted for total z-scan distance of 45 μm at 3 μm
per plane for cells in PCL scaffolds (a) and 20 μm at 3 μm per plane for cells on TCP (b) .
Blue indicates nuclei (DAPI); red indicates F-actin (Rhodamine-Phalloidin). All scale bars
indicate 100 μm.
We utilized CellTiter-Blue assay measured cell growth on PCL scaffolds. On day
7, MCF-7 cells on TCP and fibrous scaffolds proliferated to 15.00 ±0.48-fold and 13.87 ±
0.56-fold relative to day 1, respectively. There was no statistically significant difference in
proliferation rate between cells on TCP and PCL fibrous scaffolds during the first 7 days.
However, on day 9, cells cultured on TCP reached plateau, whereas cells on PCL fibrous
scaffolds continue propagating to 17.58 ± 1.43-fold relative to day 1 (Figure 3.5).
Considering the seeding cell densities were the same in these two culture systems, the
discrepancy might come from the expanding space for cell growth in 3D PCL fibrous
scaffolds. We also observed similar trends in MDA-MB-231 cells (Figure 3.6).
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Figure 3.5. The proliferations of MCF-7 in 2D tissue culture plastics and 3D PCL scaffolds
were measured at indicated time points by CellTiter-Blue assay. Results were shown as
mean ±standard deviation. Statistical significance of the differences between cells on TCP
and PCL is indicated by two asterisks (P < 0.005, n = 3).

Figure 3.6. The proliferations of MDA-MB-231 in 2D tissue culture plastics and 3D PCL
fibrous scaffolds. Results were shown as mean ±standard deviation. Statistical significance
of the differences between cells in TCP and PCL is indicated by two asterisks (P < 0.005,
n = 3).
3.2.3 Culturing MCF-7 cells on PCL Fibrous Scaffolds Induces the Expansion of CSCs
The CSC theory postulates that a small group of cells, which is selected by specific
combination of markers, are responsible for the initiation and maintenance of tumors. Chen
and his colleagues found that MCF-7 cells in 3D collagen scaffolds displayed enhanced
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stemness relative to counterparts in 2D culture.21 The collagen scaffolds provides not only
a 3D culture scaffold, but also a microenvironment with protein-protein interactions
between membrane proteins of MCF-7 cells and collagen. In this study, the unmodified
electrospun PCL scaffolds excludes the protein-protein interaction between cells and
scaffolds. We cultured MCF-7 cells on PCL fibrous scaffolds to test how this fibrous
scaffolds culture condition affects the size of CSCs population.
Aldehyde dehydrogenase, which is a detoxifying enzyme responsible for the
oxidation of intracellular aldehyde, may play a role in early differentiation of stem cells
through its role in oxidizing retinol to retinoic acid.30 Accumulating data indicates that
ALDH expression is related to cells with enhanced tumorigenic and metastatic potential.3133

In addition, based on ALDH activity, Ginestier and colleagues successfully isolated

CSCs from human breast tumors, and the expression of ALDH1 was considered as a
predictor of clinical outcomes in breast cancer patients.25 We utilized the ALDEFLUOR
assay to assess the proportion of CSCs in breast cancer cells from PCL fibrous scaffolds
and TCP respectively.34 The ratio of ALDH-positive population of MCF-7 cells increased
to 6.33% ±0.55% in 3D PCL scaffolds relative to 2.00% ±0.04% in 2D TCP after 6 days
culture without passage (Figure 3.7a and d). We also assessed CSCs in another two
luminal-type cell lines, T47D and SK-BR-3, from PCL fibrous scaffolds and TCP. The
proportion of ALDH-positive cells in T47D and SK-BR-3 increased to 6.80% ±0.58% and
18.27% ± 1.73% on PCL fibrous scaffolds from 1.82% ± 0.74% and 7.22% ± 0.19% on
TCP, respectively (Figure 3.7).
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Figure 3.7. Epithelial breast cancer cell lines, MCF-7, T47D, and SK-BR-3 cultured on
PCL fibrous scaffolds increased ALDH-positive population compared with counterparts
cultured on TCP. (a-c) After being cultured 6 day on PCL and TCP without passage, cells
were harvested and analyzed by ALDEFLUOR assay. The ALDH inhibitor,
diethylaminobenzaldehyde (DEAB) (15 μM), was added to the cell suspension in
ALDEFLUOR assay buffer with the substrate as a negative control. Numbers indicate
percentage of cells in the gated area. (d-f) The percentage of ALDH-positive cells in MCF7, T47D, and SK-BR-3 cells cultured on PCL and TCP. Results were shown as mean ±
standard deviation. Statistical significance is indicated by double asterisks (P < 0.001, n=3).
Previous research reported that mammary epithelial stem and progenitor cells can
survive and propagate in an attachment-independent manner and form floating spherical
colonies, which is termed mammospheres.26 Therefore the mammosphere formation assay
is often used to identify and enrich CSCs. To further confirm whether the PCL fibrous
scaffolds culture system increases the size of CSCs population, we measured the
mammosphere formation ability of MCF-7 cells from TCP and PCL fibrous scaffolds. We
found the MCF-7 cells from PCL fibrous scaffolds formed approximately 2.0-fold more
mammospheres than control cells from TCP (Figure 3.8a). The sphere formation efficiency
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of T47D and SK-BR-3 from PCL fibrous scaffolds increased to 1.81% ±1.07% and 3.44%
± 0.42%, relative to 1.07% ± 0.50% and 2.51% ± 0.16% for cells on TCP, respectively
(Figure 3.8b-c). Some of those spheres have a large size of around 100 μm. These spheres
probably came from multiple cells fusion.35-36 Those data suggests that CSCs expanded in
those mammary cancer cell lines when cultured in electrospun PCL fibrous scaffolds.

Figure 3.8. Epithelial breast cancer cell lines, MCF7, T47D, and SK-BR-3 on PCL fibrous
scaffolds increased the property of stemness. (a-c) Cells cultured on PCL and TCP for 6
days without passage were harvested for mammoshpere formation assay. Mammospheres
were observed under microscopy and enumerated. Results were shown as mean ±standard
deviation. Statistical significance is indicated by single asterisk (P < 0.05, n = 6) or double
asterisks (P < 0.005, n = 6). Scale bars indicate 100 μm. (d) SOX2, SOX4, OCT3/4, and
CD49f expression in MCF-7, T47D, and SK-BR-3 cultured on PCL and TCP. Results were
shown as mean ±standard deviation. Statistical significance is indicated by single asterisk
(P < 0.05, n = 3) or double asterisks (P < 0.005, n = 3).
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OCT3/4 and SOX2 function cooperatively to regulate their own transcription and
the transcription of a large set of other genes, which control the self-renewal and
pluripotency of stem cells.37 SOX4 functions in the progression of breast cancer by
orchestrating EMT.38 CD49f have been used for enrichment of normal and CSCs,39-40
which maintains the pluripotency and stemness through the direct regulation of OCT4 and
SOX2.41 In our study, transcriptional factors related to stem cells, including SOX2 and
OCT3/4, and breast CSC signatures, including SOX4 and CD49f, were enhanced in MCF7 cultured on fibrous scaffolds by 1.77 ±0.25-fold, 2.22 ±0.23-fold, 1.56 ±0.25-fold, and
2.92 ± 0.33-fold, respectively, relative to cells on TCP (Figure 3.8a). In addition, among
stemness related genes, only SOX2 were upregulated in T47D from PCL fibrous scaffolds,
while OCT3/4, SOX2, and CD49f were upregulated in SK-BR-3 cells from PCL fibrous
scaffolds, relative to cells from TCP (Figure 3.8b).
To investigate whether the effect of 3D PCL fibrous scaffolds culture on CSCs
expansion is cell-phenotype specific, we examined how CSCs response to the fibrous
scaffolds culture in high malignant basal-type cell line, MDA-MB-231 cells.
ALDEFLUOR assay, mammosphere formation assay, and gene expression pattern all show
that MDA-MB-231 cells on PCL fibrous scaffolds increased CSCs population relative to
cells on TCP (Figure 3.9). Although the proportion of CSCs in MDA-MB-231 cells
cultured on PCL fibrous scaffolds increases not as dramatically as in epithelial cell lines,
the same trend of changes in the CSC population in several breast cancer cell lines cultured
indicates that this phenomenon is not cell- phenotype specific.
Studies have demonstrated that tumor cells cultured in 3D systems displayed
properties of increased malignancy and drug resistance compared to standard 2D cultured
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tumor cells.17, 19, 42-43 Given the fact that CSCs are responsible for metastasis and drug
resistance, the expansion of CSCs in tumor cells cultured in 3D may account for this
change.

Figure 3.9. MDA-MB-231 cells cultured in PCL fibrous scaffolds displayed increased
CSCs properties and gene expression pattern of EMT. (a) The percentage of ALDHpositive cells in MDA-MB-231 cells cultured in TCP and PCL Results were shown as mean
± standard deviation. Statistical significance is indicated by double asterisks (P < 0.001, n
= 3). (b) MDA-MB-231 cultured in PCL and TCP were trypsinized and then plated in nonadherent conditions in mammosphere medium, as described in Methods. Mammospheres
were numerated. Results were shown as mean ±standard deviation. Statistical significance
is denoted by single asterisks (P < 0.05, n = 3). (c) qRT-PCR analysis was used to quantify
the expression of stem cell markers, SOX2, SOX4, OCT3/4, and CD49f. (d) qRT-PCR
analysis was used to quantify the expression of EMT markers in MDA-MB-231 from PCL
and TCP. Results were shown as mean± standard deviation. Statistical significance is
indicated by single asterisk (P < 0.05, n = 3) or double asterisks (P < 0.005, n = 3).
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3.2.4 The Enhancement of EMT-Associated Properties in Cells from PCL Fibrous
Scaffolds
The EMT is a developmental process, in which epithelial cells with tight cell
junctions and relative low migratory ability convert to mesenchymal cells with migratory
and invasive phenotype. Recent studies demonstrate that during the carcinoma progression,
some tumor cells are undergoing the EMT.44 The inducing factors of EMT include growth
factors, cell-matrix interaction, and hypoxia. In addition, EMT may also trigger the
transformation of non-stem cancer cells to CSCs, in which tumor cells are acquiring
properties of invasion, drug-resistance, chemo-resistance, and radio-resistance.27
We previously reported that culture on PCL fibrous scaffolds with either aligned
fibers or random fibers can stimulate mouse mammary cell line H605 to undergo EMT.29
Here, we investigated whether human epithelial-type breast cancer cell lines MCF-7,
T47D, and SK-BR-3 cells cultured on PCL fibrous scaffolds were undergoing EMT.

Figure 3.10. Cells from PCL fibrous scaffolds culture displayed a mesenchymal
morphology after being re-plated in TCP (right), relative cells from TCP (left). Scale bars
indicate 50 μm.
A classical definition of EMT is a multiple step process, in which cells acquire a
mesenchymal morphology and then demonstrate increased migration and invasion.45 MCF-

70

7 cells from PCL fibrous scaffolds were reseeded to TCP, of which about 10%
demonstrated elongated spindle-like morphology (Figure 3.10). There was no
morphological change for reseeded T47D and SK-BR-3 cells from fibrous scaffolds. Using
Transwell assay, we measured invasive property of MCF-7, T47D, and SK-BR-3 cells, a
characteristic associated with EMT. Cells from PCL fibrous scaffolds showed significant
increases in the number of cells passing through the membrane (Figure 3.11).

Figure 3.11. Culture on PCL fibrous scaffolds increases the invasion of MCF-7, T47D,
and SK-BR-3 cells. (a-c) MCF-7, T47D, SK-BR-3 cells from PCL displayed higher
invasive capability in Transwell invasion assay compared to counterparts from TCP. Cells
that successfully migrated through the filter pores were fixed with 3.7% paraformaldehyde
and stained with 0.5% crystal violet in 2% ethanol. Scale bars indicate 100 μm. (d-f) The
average number of migrated cells per field was assessed by counting six random fields.
Statistical significance is indicated by double asterisks (P < 0.001, n=3).
To further confirm cells on PCL fibrous scaffolds were undergoing EMT, we
measured the transcriptions of EMT related genes in cells from two different culture
conditions. The expression of EMT related transcriptional factors, including SLUG,
SNAIL, TWIST1, TWIST2, ZEB1, ZEB2, and FOXC2, and other EMT markers, including
VIM and ITGA5, were significantly upregulated in MCF-7 cells on PCL fibrous scaffolds
in comparison with cells cultured on TCP (Figure 3.14). In T47D cells on PCL fibrous
scaffolds, EMT related transcriptional factors, SNAIL, TWIST1, TWIST2, and ZEB2 were
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Figure 3.12. Immunofluorescence staining for E-cadherin in MCF-7 and T47D cells
cultured in tissue culture plastics and PCL fibrous scaffolds. Blue indicates nuclei (DAPI);
red indicates E-cadherin. All scale bars indicate 100 μm.
upregulated, compared to cells on TCP. In SK-BR-3 cells, only ZEB2, VIM, and ITGA5
were upregulated. Meanwhile, the expression of the epithelial marker, CDH-1 (Ecadherin), decreased in cells from PCL fibrous scaffolds relative to cells from TCP (Figure
3.14). Indirect immunofluorescence staining of cells with E-cadherin antibody revealed
most of cells, if not all, on fibrous scaffolds still expressed E-cadherin protein (Figure
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3.12). Western blot analysis indicates there is no significant change in protein level for Ecadherin and vimentin in cells from fibrous scaffolds relative to cells from TCP (Figure
3.13). It is probably because the cells are still undergoing the early transition of EMT,
which is a relatively slow process. For example, TGF-β normally induces EMT within
about two weeks.46 The improvement of invasion and enhancement of expression of EMT
markers suggests cells on PCL fibrous scaffolds were undergoing EMT.

Figure 3.13. After culturing for 6 days on PCL fibrous scaffolds and tissue culture plastics,
cell extracts were used for Western blot analysis to detect the expression of E-cadherin and
Vimentin. The density of each band was quantified with The Image J software and divided
by the density of the corresponding GAPDH band. The ratio is presented under each blot
after normalizing the values for TCP control as one unit.
It was reported that immortalized human mammary epithelial cells undergoing
EMT displayed a shift in CD44 expression from variant isoforms (CD44v) to the standard
form (CD44s).47 In the present study, we observed CD44v, CD44s and CD44t were all
upregulated in cells cultured on PCL fibrous scaffolds (Figure 3.15). CD24 regulates TGFβ3 and E-cadherin in oral epithelial cells during EMT.48 The downregulation of CD24 and
the upregulation of TGF-β3 in cells culture on fibrous scaffolds suggest cells were
undergoing EMT (Figure 3.15).
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Figure 3.14. PCL fibrous scaffolds culture enhanced the expression of EMT related
markers in breast cancer cells. Differential expressions of EMT markers were measured by
qRT-PCR in MCF-7 (a), T47D (b), and SK-BR-3 (c) from PCL and TCP. Results were
shown as mean ±standard deviation. Statistical significance is indicated by single asterisk
(P<0.05, n=3) or double asterisks (P < 0.005, n=3).
MDA-MB-231 cells have basal-like properties and possessed mesenchymal
phenotype due to high expression of vimentin.49-50 Indeed, the basal level of EMT related
gene in MDA-MB-231 cells is higher than in epithelial-like cells, MCF7, T47D, and SKBR-3. Culture on fibrous scaffolds further enhances the expression of EMT related genes
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in MDA-MB-231 cells (Figure 3.9). It is acknowledged that the EMT process is related to
stemness.27 If the increased CSCs came from the transformation of non-stem cancer cells
induced by EMT, CSCs proportion in mesenchymal-type cell line, MDA-MB-231, would
not change as dramatically as the epithelial-type cell lines, because the mesenchymal cell
line cannot undergo the EMT process.

Figure. 15. Real time quantitative PCR analysis of CD24, CD44 variants and TGF-β3
expression in MCF-7 and MDA-MB-231 cells cultured in 3D scaffolds compared to cells
on tissue culture plastics. Results were shown as mean± standard deviation. Statistical
significance is indicated by single asterisk (P < 0.05, n=3) or double asterisks (P < 0.005,
n=3).
Previous study suggests MCF-7 cells in 3D collagen scaffolds were induced to
undergo EMT may be due to the adaption to the hypoxia condition.51 In our study most of
cells localized on the surface of scaffolds, and a few cells infiltrated into lower layers,
which is not sufficient to induce the hypoxia condition. Therefore it might be other factor
rather than hypoxia that induced cells to undergo EMT in this case. It is acknowledged that
compressive forces generated by the interaction between cells and their surrounding
environment can cause, either directly or indirectly, alterations of cell in the structure and
function of ECM receptors to actively influence signaling pathway. EMT in the tumor
environment is a force-dependent phenomenon.52 TGF-β studies revealed that dynamic
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compression and contraction of cell-matrix interaction activates latent ECM bound TGFβ, thereafter stimulates a feedback loop to induce EMT in the cell itself.53-54 Further
research will be required to elucidate the detailed mechanism of how the 3D PCL fibrous
scaffolds induce cells to undergo EMT.
Although EMT can induce the conversion of non-stem cancer cells to CSCs, a
recent study suggests EMT and stemness are not necessarily linked.55 In the present study,
we found PCL fibrous scaffolds culture condition increased CSCs properties and induced
EMT. However, it is still unclear whether that EMT and the increase of CSCs are two
independent events or two events with causal relationship. Further work needs to be done
to understand the relationship between EMT and the increase of CSCs in electrospun PCL
fibrous scaffolds.
3.3 CONCLUSIONS
Cancer stem cells, which are responsible for the tumorigenesis, chemo-resistance,
radio-resistance, and metastases, play a vital role in the tumor initiation and regression.
Previous studies suggest that cells in traditional 2D culture fail to represent in vivo tumor
cells, due to the loss of the malignancy. In the present study, using electrospinning process,
we generated PCL fibrous scaffolds for 3D cell culture. Three epithelial-type breast cancer
cell lines, including MCF-7, T47D, SK-BR-3, cultured on PCL fibrous scaffolds showing
increased CSCs population relative to cells cultured on TCP, which may likely attribute to
the EMT process.
Recently we have developed a set of mathematical models with two negative
feedbacks to explore essential biological factors that control the CSC population during
tumor growth, in which an excellent agreement with experimental data has been achieved.
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To characterize the underlying features of CSCs induced by 3D PCL fibrous scaffolds, we
plan next to extend mathematical models as proposed by including the transformation from
non-stem cells to CSCs to further investigate whether the enrichment of CSCs by 3D PCL
fiber scaffolds is primarily due to transformation of non-stem cells to CSCs, or increasing
symmetric division or differentiation rates of CSCs, or the combination of these different
factors. With this data, we anticipated that PCL fibrous scaffolds culture system, in which
cells demonstrate higher malignancy and the expansion of CSCs, could be used as a useful
scaffold for the evaluation of novel anti-cancer drugs and the enrichment of cancer stem
cells in vitro.
3.4 EXPERIMENTS
3.4.1 Preparation of Electrospun PCL Fibrous Scaffolds
A 15% w/w solution of poly (ε-caprolactone) (PCL) (Average Mn ca. 60 kDa,
Sigma), in 1,1,1,3,3,3-hexafluro-2-propanol (HFIP) (Sigma Aldrich) were made. The
electrospinning system are placed in a humidity-controlled chamber and schematically
depicted in Figure 3.1a. The electrospinning process was conducted as follows: The
polymer solution was transferred to a 1.0 mL plastic syringe (BD) with a 21 G blunt needle
(BD precision glide). A syringe driver was used to control the solution flow rate at 15 μL
min-1. A high voltage supply (HVR Orlando, FL) was used to build up a voltage of 6-7 kV
electro filed between the needle and the grounded collector. The distance between the
collector and needle was fixed at 10 cm. The PCL fibrous scaffold was fertilized by
immersing into 75% ethanol for 20 min, dried overnight and then irradiated under
ultraviolet light for 20 min in a laminar flow hood.
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3.4.2 Cell Culture
Human breast cancer cell lines MCF-7, T47D, SK-BR-3, and MB-MDA-231 were
purchased from the American Type Culture Collection. MCF-7 and MDA-MB-231 cell
were cultured in Dulbecco’s modified Eagle’s medium (DMEM, #D6046, Sigma–Aldrich)
supplemented with 10% heat inactivated fetal bovine serum (Hyclone, Thermo Scientific),
100 U mL-1 penicillin and 100 μg mL-1 streptomycin (Gibco BRL, Invitrogen Corp.,
Carlsbad, CA, USA). T47D was maintained in RPMI-1604 media (Sigma-Aldrich)
containing 10% FBS, 100 U mL-1 penicillin and 100 μg mL-1 streptomycin. SK-BR-3 was
maintained in KBR3 cells were grown in McCoy's 5A (Sigma-Aldrich) supplemented with
10% FBS, 10% FBS and 100 U mL-1 penicillin and 100 μg mL-1 streptomycin. Cells were
cultured in a 5% CO2 humidified incubator at 37°C. Sterilized PCL fiber scaffolds were
soaked in media 30 min prior cell seeding. Cells in exponential growth phase were
trypsinized by 0.25% trypsin and seeded on PCL fibrous scaffold at a density of 5.2 × 10 3
cells per cm2. The cells used in experiments were cultured on PCL and TCP for 6 days
without passage, unless otherwise specified.
3.4.3 Confocal and Scanning Electron Microscopy Studies
Cells on PCL fiber scaffolds were rinsed with phosphate buffered saline (PBS)
twice and fixed with 4% paraformaldehyde for 20 min at room temperature. Then scaffolds
were rinsed with PBS. Cells were permeabilized with 0.2% Triton X-100 for 10 min. To
prevent non-specific labeling, 3% bovine serum albumin (BSA) in PBS were applied as a
blocking buffer for 20 min. Actin cytoskeleton was stained with rhodamine phalloidin
(Cytoskeleton Inc.) (1:200) in a blocking buffer for 20 min, and nuclei were stained with
4′,6-diamidino-2-phenylindole (DAPI) (Invitrogen) in a blocking buffer for 10 min. The
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fluorescence was visualized and captured under confocal microscope (Olympus IX81) with
DAPI filter and Cy3 filter set. The morphology of PCL fiber scaffolds were examined by
a field emission scanning electron microscopy (FEI Quanta 200 ESEM). PCL scaffold
samples were dried with nitrogen, and coated with gold for 30 seconds with sputter coater.
To examine the uniformity of the fiber diameters several areas were imaged. Fiber
diameters were measured using image J (National Institutes of Health).
3.4.4 ALDEFLUOR Assay
The ALDEFLUOR kit (Stem Cell Technologies, Durham, NC, USA) was used to
identify the cancer stem cell population with high ALDH enzyme activity. Briefly, the
cells were suspended in ALDEFLUOR assay buffer containing ALDH substrate BAAA (1
μM) in a concentration of 1 × 106 cells mL-1 and incubated for 45 min at 37°C. As a
negative control, the ALDH inhibitor, diethylaminobenzaldehyde (DEAB) (15 μM) were
added to the cell suspension in ALDEFLUOR assay buffer with BAAA. A Cytomics
FC500 flow cytometry system (Beckman Coulter Inc., Miami, FL, USA) was used to detect
the ALDH-positive cell population.
3.4.5 Cell Proliferation Assay
The effect of PCL fiber scaffolds on cell growth was assessed by CellTiter-Blue™
Cell Viability Assay (Promega, Madison, WI). The cell titer blue reagent was added to the
medium directly (100 μL per 1 mL medium) and incubated for four hours at 37°C.
Fluorescence at 560ex/590em nm filter setting was measured using a Tecan infinite M200
plate reader (Tecan, Salzburg, Austria). After correction of background fluorescence, the
intensity of fluorescence for each sample was normalized by the first day intensity of
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fluorescence. The cell viabilities on day 1, 3, 5, 7, 9, 11, and 13 were determined. Three
independent experiments were determined for each case.
3.4.6 Mammosphere Formation Assay
Cells from 2D culture or 3D PCL fibrous scaffolds were plated in ultralow
attachment six-well plates (Corning, Acton, MA, USA) at a density of 10000 cells mL-1
for MCF-7 and 1000 cells mL-1 for MDA-MB-231. in serum-free DMEM/F12 medium
(Invitrogen, Carlsbad, CA, USA) supplemented with 20 ng mL-1 epidermal growth factor
(sigma, St Louis, MO, USA), 10 ng mL-1 basic fibroblast growth factor (Sigma), 5 μg mL1

insulin (Sigma), 1 × B27 supplement (Invitrogen) and 0.4% bovine serum albumin

(Sigma). Cells were cultured in a 5% CO2 humidified incubator at 37°C for a week. The
number of mammospheres was counted under microscopy. Three independent experiments
were performed for each group.
3.4.7 RNA Extraction and Quantitative Reverse-Transcription PCR
Total RNA was isolated using RNeasy mini purification kit (Qiagen). Quantitative
reverse-transcription PCR (qRT-PCR) was performed in two steps. Isolated RNA reversetranscribed with qScriptTM cDNA synthesis kit (Quanta Biosciences Inc.) and then
Quantitative (Real-time) PCR was performed with Bio-Rad iCycler with My iQ™ camera
detection system and the method used was 40 cycles of PCR (95°C for 30 s, 60°C for 15 s,
72°C for 30s), after initial denaturation step of 5 min at 95°C. In a 25 μL total volume of
reaction mixture, 12.5 μL iQ SYBR-Green™ SuperMix (Bio-Rad), 400 nM of both
forward and reverse primers (Table 3.1) and the cDNA template at a final concentration of
25 ng μL-1 were employed. Data analysis was performed using 2–CT method for relative
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quantification,56 and all samples were normalized to GAPDH expression as the internal
control.
3.4.8 Transwell Invasion Assay
The invasion chamber consisted of a cell culture insert with a membrane pore size
of 8 μm in a 24-well plate (BD BiocoatTM MatrigelTM Invasion Chamber, BD Biosciences,
Franklin Lakes, NJ). Cells cultured in 2D and 3D were trypsinized and washed by PBS.
Then cells were plated in the top chamber with Matrigel-coated membrane at a density of
2.5 ×105 cells per well for MCF-7 and 1 ×106 cells per well for SK-BR-3 and T47D. Cells
were plated in the serum free medium and medium with 10% FBS was used as a
chemoattractant in the lower chamber. The cells were incubated in a 5% CO2 humidified
incubator at 37°C for 72 h. Cells fail to invade through pores were removed by a cotton
swab. Cells on the lower surface of the membrane were fixed 3.7% paraformaldehyde and
stained with 0.5% crystal violet in 2% and counted under a microscopy.
3.4.9 Statistical analysis
All assays were performed in triplicates unless otherwise stated. Data are indicated
as mean ±standard deviation. Comparisons between two groups were done using unpaired
student’s t-test.
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Table 3.1. List of primers
Gene
Name
SOX2

Forward sequence 5’-3’

Reverse sequence 3’-5’

GCTTTTGTTCGATCCCAACTTTC

OCT3/
4
SOX4

CGAAAGAGAAAGCGAACCAGTATC

ATGGATTCTCGGCAGACTGATT
C
AGAACCACACTCGGACCACATC

ITGA
6
ITGA
5
SNAI
L
SLUG
ZEB1
ZEB2

GCATGATGATAGCATATGTGTTCAGG
T
CAAATGCAGGCACTCAGGTTC

CGGCATATTGCACAGGATGGA

GTCAGCAGCTCCTATATGTGACCAGA

CCCTCGGGATCCAACTCCAG

GCCTAGCGAGTGGTTCTTCTG

CTGCTGGAAGGTAAACTCTGGA
TT
GTGGAATGGAGCAGCGGTAGT
TTGAGAATAAGACCCAGAGTGT
GAGAAG
CATCAAGCAATTCTCCCTGAAA
TC
GCCCTGTTTCTTTGAATTTGGAT

GCGAACTGGACACACATACAGTGAT
GAGACATAAATATGAACACACAGGT
AAAAGAC
CCACCAGTCCAGACCAGTATTCCT

TWIS
T1
TWIS
T2
VIM

GCCGGAGACCTAGATGTCATTGT

FOXC
2
CDH1
CD24

CAGCAGCAAACTTTCCCCAAC

GCTGCCCTCTGACAAGCTGA
GAAGGCGAGGAGAGCAGGATT

AGGCCAAGCAGCAGTACATT

GCATCAAGATCCCAGCGAGA

CTTATTGTCCATCTCGTCGCTCT
G
AGAAGTTTCGTTGATAACCTGTC
CA
CAGTATTTCGTGCAGTCGTAGG
AGTAG
ATTCACATCCAGCACATCCA

CD44t

AAACAACAACTGGAACTTCAAGTAA
CTC
TCCAACACCTCCCAGTATGACA

CD44v
CD44s

CCACATTCTACAAGCACAA
TCCCTGCTACCAGAGACCAAGACA

GAPD
H
TGFbeta3

GAGTCAACGGATTTGGTCGTAT

GGCAGGTCTGTGACTGATGTAC
A
CTGTTGCCAAACCACTGTTCC
ACCAGAGGTTGTGTTTGCTCCAC
C
ATGGGTGGAATCATATTGGAAC

AGCGGAATGAGCAGAGGATCGA

CTCAACAGCCACTCACGCACAG
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GGTGGTGGCATTAGTTGGATTT
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CHAPTER 4
BIOLOGICAL THIOLS-TRIGGERED HYDROGEN SULFIDE RELEASING
MICROFIBERS FOR TISSUE ENGINEERING APPLICATIONS
4.1 INTRODUCTION
Hydrogen sulfide (H2S) has long been considered as a malodorous toxic gas. Abe
and Kimura first reported the possible role of endogenous H2S in the neuromodulation,1
indicating the biological relevance of H2S as a gasotransmitter. Together with nitric oxide
(NO) and carbon monoxide (CO), H2S forms part of a group of active gaseous molecules
that modulate cellular functions through intracellular signaling cascades.2 Most, if not all,
of endogenous formation of H2S is attributed to four enzymes, cystathionine β-synthase
(CBS), cystathionine γ-lyase (CSE), and the tandem enzymes cysteine aminotransferase
(CAT) and 3-mercaptopyruvate sulfurtransferase (3-MST).3-5 Tightly controlled
endogenous H2S has involved in diverse physiological and pathophysiological processes,
including learning and memory, neurodegeneration, regulation of inflammation and blood
pressure, metabolism, and anti-apoptosis.6 Possessing all positive effects of NO without
generating a toxic metabolite such as ONOO-,7 H2S holds great therapeutic potential for
various diseases and has drawn increased attention of biomedical scientists.
Limited available H2S releasing agents (i.e. H2S donors), such as sulfide salts,
natural polysulfide compounds such as diallyl trisulfide, synthetic H2S donors such as
Lawesson’s reagent derivative, GYY4137, have been developed and applied for the studies
of the physiological and pathological functions of H2S.8 Recently, a polymeric H2S donor
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synthesized by conjugating 5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione (ADT-OH) to
polymers showed effects of potentiating lipopolysaccharide-induced inflammation and
altered cellular trafficking.9 However, the shortage of aforementioned H2S donors is that
the H2S release is either too fast or uncontrollable, which poorly mimic the biological
generation of H2S. To overcome this drawback, we have developed a series of N(benzoylthio)benzamides derivatives (NSHD), which are controllable and have a relative
slow-releasing profile.10 The H2S release of these donors can be triggered by biological
thiols such as cysteine and glutathione (GSH), which are prevail in the biological system.
Therefore, NSHDs are promising candidate for H2S-based therapeutic strategy.
Electrospinning is a simple, cost-effective, and versatile technique in which natural
or synthetic polymers are fabricated into fibers with diameters ranging from tens
nanometers to micrometers. The unique advantages, such as high surface to volume ratio,
adjustable porosity and fibers orientation, and the flexibility to form various sizes, make
the electrospun fibers an ideal system for a broad range of biomedical applications, such
as wound dressing, blood vessel tissue engineering, neural repair, bone or cartilage tissue
engineering, and controlled drug release, as described in several reviews.11-13 Previously,
researchers

have

functionalized

electrospun

fibers

with

biological

relevant

macromolecules, such as low molecular weight heparin,14 growth factor BMP2,15, neural
growth factor,16 and specific genes.17 Notably, several groups have generated electrospun
fibers with capability to release gaseous messenger nitric oxide.18-22 Though emerging role
of H2S in physiological and pathophysiological processes indicates H2S holds great
therapeutic potential,23 to the best of our knowledge, no H2S-releasing electrospun fibers
(H2S-fibers) has been generated and evaluated so far.
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Fibrous scaffolds generated by electrospinning have been used to generate
substitutes and grafts for various tissue regeneration and achieved significant progress. 12
The electrospun fibers served as cell scaffolds for the therapeutic cells to adhere,
proliferate, and differentiation, in the damaged tissues or organs.11 However, in the process
of transplantation of organs, tissue substitutes, and therapeutic cells, ischemia in vitro and
post-transplantation is the most well-known cause of malfunction of transplanted grafts. 2425

Since the production of endogenous H2S and the exogenous administration of H2S elicit

a wide range of protective actions, especially in cardiovascular systems, including
vasodilation, anti-inflammatory, antioxidant, and down regulation of cellular metabolism
under stress,23, 26 H2S-fibers would enhance the regenerative capacity of tissue engineering
grafts by protecting encapsulated cells from ischemia.
We hypothesized that electrospinning biodegradable polymers doped with a H2S
donor (NSHD1) will generate H2S-fibers with a controllable slow-releasing profile, which
could be used as cell scaffolds to protect cell from ischemia reperfusion injury. To test this
hypothesis, we fabricated H2S-fibers by electrospinning biodegradable polycaprolactone
solution containing NSHD1. The resultant H2S-fibers not only supported the growth of
cardiac myoblasts H9c2 and fibroblast NIH 3T3, but also protected cells from hydrogen
peroxide (H2O2) induced oxidative damage by releasing H2S. Given the broad biological
functions of H2S, we anticipate this H2S-releasing scaffold will have great potential for
biomedical applications.
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4.2 RESULTS AND DISCUSSION
4.2.1 Fabrication of H2S-fibers
Electrospinning is a simple method to generate fibrous scaffolds with diameters
ranging from nanometers to microns. The generation of fibers with desired diameters
highly dependent on a variety of parameters such as solution concentration, solvent vapor
pressure, conductivity, surface tension, applied voltage, gap distance, and flow rate.27
Previously, several studies have explored how different parameters affect fiber
diameters.28-30 However, results from different groups are inconsistent primarily due to
differences in the control of ambient environments and home-made devices. Therefore,
optimizing the electrospinning setup is essentially required before incorporating H2S donor
into fibers with desired morphology. The biodegradable polycaprolactone (PCL) is being
used in the present study because it has been approved by Food Drug Administration
(FDA) in specific devices used in human body for various biomedical applications and
fabricated into cellular scaffolds for culturing different types of cells.31
In this study, by simply adjusting PCL concentrations, we fabricated various
microstructures, including spheres, beaded fibers and uniform fibers using our home-made
electrospinning equipment (Figure 4.1). This is consistent with previous report of the
transition stage between the sphere and fiber morphologies.32 The fine uniform fibers were
eventually produced as the PCL concentration increased to 6%. Although the resulting
electropining products that lack of uniform fibrous morphology cannot be used as cell
scaffolds, Fattahi and colleagues had systematically investigated the drug-loading
application of microspheres by encaptulating anti-tumor medicine.33
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Figure 4.1. Electrospinning setup. (a) Schematic illustration of electrospinning setup. SEM
images of (b) polycaprolactone (PCL) microspheres (1%), (d) microsphere/nanofiber
composites (2%), (f) fibers with bead defects (4%), and (h) uniform continuous fibers (6%).
(c), (e), and (f) are enlarged images of b, d, and f, respectively.
Previous studies suggest altering solution concentrations remain the most
convenient and effectively way for tuning the fiber diameters.30 In order to form uniform
fine fibrous structure with different diameters, PCL solutions with concentrations ranging
from 6% - 12% were prepared for electrospinning. For generating H2S-fibers, the H2S
donor, NSHD1, was being added into each of the solutions with a constant ratio to PCL
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(10 wt% with respect to PCL). The structure and activation of NSHD1 are shown in Figure
4.2g. PCL solutions with concentrations of 6%, 9%, 12% generated homogeneous fibrous
scaffolds with diameters of 0.51 ± 0.16, 0.98 ± 0.16, 1.47 ± 0.18 micron, respectively
(Figure 4.2a-c). In addition, the SEM images showed that H2S donor/PCL solutions
generated H2S-fibers with uniform morphology (Figure 4.2d-f). The surfaces were smooth
and no crystals were observed, which indicated that the loaded H2S donors were evenly
distributed in the fibers. The fibers formed from H2S donor/PCL solutions have shown
similar diameters as the fibers generated from PCL solution (PCL-fibers) at each of the
solution concentrations (Figure 4.2h).

Figure 4.2. Morphology of H2S-fibers. (a) SEM images of H2S-fibers (Top images) and
PCL-fibers (bottom images) generated from 6%, 9% and 12% w/v solutions. All images
share the same scale bar as indicated in the bottom right image. (b) The H2S donor, NSHD1, releases H2S in the presence of cysteine o GSH. (c) Fiber diameters plot as a function of
solution concentrations. The dopant, NSHD1, has no obvious effect on fiber diameters.
Data are expressed as mean ± SE, and statistical significance was assessed using two-way
ANOVA. ** indicates P < 0.05; NS indicates not significant (n = 200).
The energy dispersive X-ray (EDX) spectra were employed to determine the
presence of the H2S donor in the fibrous matrix via detection of sulfur. The data have shown
that the presence of sulfur peak in H2S-fibers, where there is no sulfur peak in PCL-fibers
(Figure 4.3a-b). Furthermore, the Fourier transform infrared spectrometry (FTIR) spectrum
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was applied to confirm the incorporation of NSHD1 into H2S-fibers. The FTIR spectra of
PCL-fibers showed peaks located at 2945, 2866, and 1723 cm-1, which were assigned to
the stretching vibration of –C=O bonds (Figure 4.3c). The FTIR spectra of the H2S-fibers
showed additional absorption peaks at 3315, 1600, and 690 cm-1 compared with the spectra
of the PCL-fibers, due to the presence of H2S donor (Figure 4.3e). Those additional
absorption peaks at 3315, 1600, and 690 cm were attributed to amide N-H stretch, amide
N-H bending, and aromatic C-H bending, respectively, which matched the peaks of donor
alone (Figure 4.3d). These data suggested that the donor has been successfully doped into
the electrospun fibrous scaffolds.

Figure 4.3. EDX and FT-IR analysis of PCL-fibers and H2S-fibers. EDX spectrum shows
the comparison between PCL-fibers (a) and H2S-fibers (b). The red color indicates the
sulfur peak. FT-IR spectrum of (c) PCL-fibers, (d) NSHD1, and (e) H2S-fibers.
Since the alignment of various types of cells are essentially important for cells to
form proper organization and fulfill biological function, such as parallel arrangement of
myotubes,34 biomaterials with anisotropic property are desired in tissue engineering.35
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Using a homemade rotating collector, we generated aligned fibrous scaffolds by
electrospinning (Figure 4.4).36

Figure 4.4. Characterization of aligned and randomly oriented H2S-fibers. SEM imaging
depicted the spatial organization of H2S-fibers in aligned (a) and random (b) orientation.
SEM images share the scale bar in (b). The distributions of the fiber orientation on aligned
(c) and random fibers (d) are shown below each graph.
4.2.2 Fabrication of H2S-fibers
H2S has recently been recognized as an endogenously generated signaling molecule
with potent cytoprotective actions.37 Although the exact mechanism of action is still under
investigation, the production of endogenous H2S and the exogenous administration of H2S
elicit a wide range of protective actions, especially in cardiovascular systems, including
vasodilation, anti-inflammatory, antioxidant, and down regulation of cellular metabolism
under stress.23, 26 Therefore fabrication of scaffolds capable of releasing H2S release is a
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promising therapeutic strategy. Here we investigated the H2S releasing profiles of H2Sfibers with different fiber diameters. To evaluate the rate of H2S release from H2S-fibers
or donor alone, we measured H2S release using two different methods: (1) instantaneous
H2S monitor with zinc acetate being added into each aliquot and (2) cumulative H2S release
with zinc acetate being added into the reacting mixture to estimate the releasing halflives.38
As explained previously, our H2S donor can be activated by biological thiols such
as cysteine and GSH. The biological thiols-triggered H2S donors enable resultant H2Sfibers carry the advantage of controllable H2S release. In a study of 106 healthy adults, the
plasma thiols, including homocysteine, GSH, and cysteine, were about 300 to 400 μM.39
Based on our previous study, those free thiols were able to trigger H2S release of our
donors.10 Since the cysteine is one of the most prevail biological thiols in the plasma and
gives fast activation of NSHD1, it was used as the representative activator of H2S-fibers in
the following experiments.
Before investigating the H2S release kinetics of H2S-fibers, we first measured the
H2S release of H2S donor alone. As shown in a typical H2S release curve of NSHD1 in pH
7.4 phosphate buffer (Figure 4.5a), the concentration of H2S released from the donor
reached a maximum value at 40 min (the peaking time), and then started to decreased,
presumably due to volatilization, which is consistent with previously report.10 The half-life
of the donor for the pseudo-first-order kinetic plots was determined and found to be about
14 min.
Although various H2S donors have been reported for cellular studies, the fast and
uncontrollable H2S release of those donors compromised their capacity to mimic the
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physiological generation of H2S. Compared with donor alone, we expect the H2S-fibers
demonstrate extended H2S-releasing profiles. Meanwhile, since H2S-fibers generated from
6%, 9% and 12% polymer solutions were 0.51 ±0.16, 0.98 ±0.16, and 1.47 ±0.18 micron
in diameter, respectively, those fibers with different diameters might give different H2S
release kinetics. As our expectation, the peaking times for H2S-fibers generated from 6%,
9%, and 12% solutions were 120, 160, and 210 min, respectively (Figure 4.5b). The H2S
releasing half-lives of H2S fibers from 6%, 9%, and 12% were prolonged approximately
10-50 folds, compared with donor alone. Furthermore, H2S-fibers generated from 12%
solutions demonstrated prolonged and evenly distributed H2S release, relative to others.
These data indicate that H2S-fibers significantly prolonged H2S release and might better
mimic the biological H2S generation.

Figure 4.5. Release profiles of H2S-fibers. (a) H2S release kinetics of NSHD1 in the
presence of 1 mM cysteine. (b) H2S release kinetics of H2S-fibers generated from 6%, 9%
and 12% w/v H2S donor/PCL solutions (H2S donor:PCL = 1:10). Data are expressed as
mean ± SEM (n = 3). SEM images of H2S-fibers generated from 6% (c), 9% (d) and 12%
(e) w/v H2S donor/PCL solutions after in vitro release in pH =7.4 buffer solutions for 48 h.
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We next investigated the release of NSHD1 from H2S-fibers. NSHD1 has a UV
absorbance peak at λmax = 242 nm. Thus, the amount of NSHD1 released from the fibers
was determined by UV spectroscopy using a predetermined calibration curve C = 91.5751A
– 1.5833 (R = 0.9988) where C is the concentration of NSHD1 (μM) and A is the solution
absorbance at 242 nm (Figure 4.6a-b). The initial burst release followed by the relatively
steady release was observed. The burst release was attributed to release of NSHD1 from a
superficial area of the electrospun fibers. The smaller diameter fibers exhibited higher burst
release feature, which is consistent with previous study.40 After the initial burst release, the
NSHD1 release of 12% H2S-fibers were slower than 6% and 9% H2S-fibers (Figure 4.6b).
This is due to that the larger diameter of 12% H2S-fibers make the drug harder to diffuse
from the interior of the fibers compared to others. In addition, the higher specific surface
areas of 6% and 9% H2S-fibers are beneficial to drug release. After first 24 hours, the
NSHD1 release of all H2S-fibers reached plateau and in the next 70 hours (Figure 4.6c),
the NSHD1 concentration slowly reduced, this might be due to the hydrolysis of the
NSHD1, which has been reported in another H2S donor with similar structure.38
H2S-Release capacity of NSHD1 were significantly reduced upon being loaded into
fibers. This might be due to multiple reasons. First of all, the high voltages might lead to
partially degradation of NSHD1. Secondly, the accessibility of NSHD1 towards the
activator (cysteine) were influenced after doped into fibers. Thirdly, when we measured
the release kinetics in vitro, the oxidation of the activator would also affect the release
kinetics. Further investigation needs to be done to address the loading efficiency of NSHD1
in detail.
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Figure 4.6. Cumulative Release of H2S Donors from H2S-fibers. (a) UV absorbance of
NSHD1 in various concentrations PBS solutions ( 1 – 100 μM). (b) Linear regression
analysis the donor concentration vs absorbance. (c) Cumulative release of NSHD1 from
H2S-fibers in first 10 hours. (d) Cumulative release of NSHD1 from H2S-fibers over 85
hours. All data were expressed as mean ±SEM (n = 3).
After 48 h incubation in PBS at pH 7.4 with excess of cysteine, the H2S fibers were
subjected to SEM imaging. Compared with the original formation, the fibrous structure of
electrospun fibrous scaffolds maintained a 3D fibrous morphology, albeit all the fibers
shown slightly swollen (Figure 4.5c-e). This might be because of the chain relaxation of
the matrix polymer after incubation in the PBS. Since all the fibrous scaffolds remained
stable and maintained the 3D structural feature, the fibrous scaffolds can be applied as
tissue engineering scaffolds to support the proliferation of cells after releasing H2S.
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Since 12% solution containing the H2S donor generates 1.5 micron H2S-fibers with
prolonged and evenly distributed H2S release. For the cell experiments, 12% polymer
solution was chosen for the fabrication of H2S-fibers. In addition, the aligned H2S-fibers
have shown similar release kinetics to random H2S-fibers. The aligned fibers have been
reported to promote cells alignment to potentiate their anisotropic properties. Thus H2Sfibers with aligned orientation were applied for further investigation of cytoprotection.
4.2.3 Cytocompatibility of H2S-fibers

With these H2S-fibers in hand, we next explored their cytocompatibility. Previous
studies revealed H2S protects cardiac cells from myocardial ischemia reperfusion injury.4041

In an in vitro model of cutaneous tissue transplantation, H2S significantly decreased

apoptosis of fibroblasts caused by ischemia reperfusion injury.42 Given the potential
applications of H2S-fibers in those scenarios, H9c2 cardiac myoblasts and NIH 3T3
fibroblasts were chosen as the representatives for the cytocompatibility test.
Before investigating cytocompatibility of H2S-fibers, we first tested cytotoxicity of
NSHD1 to H9c2 cardiomyoblasts. NSHD1 did not exhibit significant cytotoxicity at low
concentrations (< 40 µM). However, the cytotoxicity was observed when higher
concentrations (> 80 µM) of NSHD1 were applied. After H9c2 cells were incubated with
NSHD1 (160 µM) in the presence of cysteine (480 µM), NSHD1’s cytotoxicity was
completed suppressed (Figure 4.7). Considering that cysteine and GSH are relative rich in
living systems, we envision NSHD-induced cytotoxicity could be diminished or avoid.
To investigate cytocompatibility of H2S-fibers, H9c2 and NIH 3T3 cells were
cultured in H2S-fibers for 24 hours and subsequently examined by CellTiter-Blue assay.
We observed 50% reduction of cell viability for H9c2 cells cultured on H2S-fibers
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compared to PCL-fibers, when no cysteine were added into the culture medium (Figure
4.8a). Interestingly, we did not observe cytotoxicity towards NIH 3T3 cells (Figure 4.8b).
However, when being cultured in medium containing 250 μm cysteine, both H9c2 and NIH
3T3 cells on H2S fibers maintained similar viability with cells on PCL-fibers (Figure 4.8).
These data demonstrated that our H2S fibers were non-toxic to cells in the presence of
biological thiols. Given that the concentration of biological thiols including cysteine,
homocysteine, and GSH, is ranging from several hundred micromolar to several milimolar
in vivo,39 H2S-fibers should be non-toxic to cells and tissues when they are being used as
an implanted scaffolds.

Figure 4.7. Cytotoxicity of NSHD1 in the absence or presence of cysteine. Data were
expressed as the mean ±SEM. * indicates P < 0.05 vs. Control (Ctrl). ** indicates P < 0.01
vs. Ctrl.
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Figure 4.8. Effects of H2S-fibers on cell viability. NIH 3T3 cells. (a) and H9c2 cells (b)
were cultured in fibrous scaffolds in presence of cysteine at indicated amount for 24 hours.
CellTiter-Blue assay was performed to measure cell viability. Data were expressed as the
mean ± SEM (n = 6). * indicates P < 0.05 vs. Control group (cells in PCL fibers). **
indicates P < 0.01 vs. Control group.
To observe cells in H2S-fibers, H9c2 cells cultured in the fibrous scaffolds at day
1, day 3, and day 5 were stained with phalloidin and DAPI, then observed under
fluorescence microscopy (Figure 4.9). The aligned fibers promoted H9c2 to align along the
fiber axis. Previous research suggested that this guided alignment could strongly promote
myoblasts formation.43 In addition, H9c2 cells increased in number during cultured in H2Sfibers. At day 3 and day 5, H9c2 were found to reach an estimated confluence of 50% and
90%, respectively, indicating that H9c2 proliferated in H2S-fibers. In addition, we did not
observe morphological changes of the cells in H2S-fibers. Similar results were observed in
H9c2 cells cultured in PCL-fibers (Figure 4.10). Taken together, we conclude that H2S
fibers are cytocompatible and can support the cell proliferation.
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Figure 4.9. Fluorescence images of H9c2 cells cultured in H2S-fibers. H9c2 cells were
cultured in aligned fibrous scaffolds for 5 days. In each time point samples were fixed
and stained by Phalloidin (red) and DAPI (blue). Images were taken with fluorescence
microscope. All images share the scale bar in (i).

Figure 4.10. Fluorescence images of H9c2 cells cultured in H2S-fibers and PCL-fibers.
H9c2 cells were seeded in fibrous scaffolds for 1 day. Then samples were fixed and stained
by Phalloidin (red) and DAPI (blue). Images were taken with fluorescence microscope. All
images share the scale bar in (f).
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4.2.4 H2S-fibers Protecting Cells from Oxidative Damage
After examining the cytocompatibility of cells with H2S-fibers, we then used a
selective H2S probe, WSP-5,44 to monitor the H2S in cells cultured in H2S-fibers. H9c2
cells and NIH 3T3 cells were seeded in the H2S-fibers for 12 hours in the presence of 250
μM cysteine. Then WSP-5 was applied to monitor the intracellular H2S. As expected, cells
in H2S-fibers showed enhanced fluorescent signals compared to cells in PCL-fibers (Figure
4.11). The H2S signal could be observed even after 24 hours of incubation (Data not
shown), indicating a sustained release of H2S from H2S-fibers.

Figure 4.11. H2S detection in NIH 3T3 cells and H9c2 cells. NIH 3T3 (top 2 rows) and
H9c2 cells (bottom two rows) were cultured on H2S-fibers (first and third rows) or PCLfibers (second and last rows) for 12 hours, 100 µM of a H2S fluorescent probe (WSP-5,
green channel) was used to detect H2S production in cells. (d) and (k) are higher
magnification view of (a) and (h), respectively. (a-c), (e-g), (h-j), and (l-n) share the scale
bar as in (n). (d) and (k) share the scale bar as in (k).
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Figure 4.12. H2S-fibers protected cells from H2O2 induced oxidative injury. (a) H9c2 cells
were treated with H2O2 at indicated concentrations for 24 h. Before treated with 400 M
H2O2 for 24 h, H9c2 (b) and NIH 3T3 (c) were cultured in either PCL-fibers (Donor -) or
H2S-fibers (Donor +) with or without 250 M cysteine. Cell viability was measured by
CellTiter-Blue assay. Data were shown as the mean ± SEM. ** indicates P<0.01 vs.
Control group (cells in PCL-fibers without H2O2 treatment). † indicates P<0.01 vs. cells in
PCL-fibers with H2O2 treatment group.
A previous study revealed that H2O2 is a major player in ischemia reperfusion
injury, and ischemia causes a dramatic increase of myocardial H2O2 content.45 Therefore,
H2O2 has been applied to H9c2 cells as an in vitro ischemia model.46 Recent studies
suggested H2S holds a great potential in protecting cells from ischemia reperfusion injury.
To test the biological function of our H2S-fibers, we evaluated the cytoprotective effect of
H2S-fibers against H2O2 induced oxidative damage. We first exposed H9c2 cells to H2O2
in a range of 0 to 1000 μM for 24 h in serum free medium. The CellTiter-Blue assay was
performed to determine the viability of H9c2 cells treated by H2O2. A dose-dependent loss
of cell viabilities was observed in H9c2 with concentrations between 100 to 700 μM
(Figure 4.12a). A concentration of 400 μM of H2O2 that could reduce 50% of cell viability
was chosen for later studies. The H9c2 cells and NIH 3T3 cells were seeded in H2S fibers
or PCL fibers for 24 hours with 250 μM cysteine. Then cells in the fibers were switched
into serum free medium containing 400 μM H2O2 for 24 hours. The cell viabilities were
measured by CellTiter-Blue assay. Our data demonstrated that viabilities of cells in H2S
fibers were significantly higher than ones in PCL-fibers. However, if there was no extra
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cysteine being added in the culture medium, the cytotoxicity of H2S-fibers synergized the
effect of H2O2 to further decrease the cell viabilities (Figure 4.12b-c). Interestingly, the
cells on 3D fibrous scaffolds were more sensitive to H2O2 treatment than cells on tissue
culture plastics, probably due to the alteration of culture dimensions.47 The protective effect
of H2S fibers were observed up to 36 hours and disappeared at 48 hours (Figure 4.13).

Figure 4.13. Time course of H2S-fibers protecting cells from H2O2 induced oxidative
injury. H9c2 cells (a) and NIH/3T3 cells (b) were cultured on H2S-fibers of PCL-fibers
with 250 M cysteine for indicated time. And then cells were subject 400 M H2O2 for 24 h.
Cell viability was measured by CellTiter-Blue assay and then normalized by the viability
of cells on PCL-fibers without H2O2 treatment. Data were shown as the mean ± SEM (n =
4). * indicates P<0.01.

Figure 4.14. H2S-fibers reduced levels of reactive oxygen species (ROS) production in
H2O2 treated H9c2 cells. Representative images of DHE-fluorescence intensity were taken
2 h after H2O2 treatment for cells in PCL-fibers (a-b) or H2S-fibers (c-d) with (right
column) or without 250 μM (left column) cysteine. (e) H2S-fibers significantly decreased
DHE-fluorescence intensity in H9c2 cells in presence of 250 μM cysteine compared to
other group (n = 20). Data were expressed as the mean ±SEM. ** indicates P < 0.01.
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Increased generation of reactive oxygen species (ROS) during both ischemia and
reperfusion plays an essential role in the pathophysiology of intraoperative myocardial
injury.48 Cardioprotective effect of H2S during ischemia reperfusion results from
decreasing the levels of ROS production.49 To confirm that our H2S fibers have the
cytoprotective function, we investigated the ROS production of H9c2 cells in H2S-fibers
or PCL-fibers under H2O2 treatment. After 2 hours of exposure to H2O2, the ROS
generation was measured using live cell imaging with a ROS probe, dihydroethidium
(DHE).50 The intracellular fluorescence intensity in the nuclei, which reflected ROS
generation, was significantly lower for cells cultured in H2S-fibers with 250 μM cysteine
than counterparts in PCL-fibers and H2S-fibers without cysteine (Figure 4.14). In a control
study performed in tissue culture plastics, H9c2 cells pretreated with 160 μM NSHD1 and
480 μM cysteine showed significantly decreased DHE fluorescence signal after 2 h
exposure to 400 μM H2O2, compared to cells without pretreatment (Figure 4.15). These
data suggest that our H2S-fibers can effectively protect cells from H2O2 induced oxidative
injury by releasing H2S.

Figure 4.15. H2S donor, NHSD1, prevents H2O2 induced ROS production in H9c2 cells.
Cells pre-treated with 160 μM NHSD1. (c-e) showed significant reduction of DHE
fluorescence signal compared to cells without pre-treatment (a-c). All images share the
scale bar in (f).
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4.3 CONCLUSIONS
Hydrogen sulfide has been gaining increasing attentions recently due to its broad
range of biological functions. Here, combining electrospinning technique with a H2S
donor, we generated fibrous scaffolds with controllable H2S release. By adjusting fiber
diameters, tunable H2S releasing profiles have been achieved. Compared to donor alone,
H2S-fibers have demonstrated prolonged and evenly distributed H2S release. Furthermore,
we investigated the cytoprotective effects of H2S-fibers against H2O2 induced cell injuries.
Our data demonstrated that H2S-fibers released H2S to the cells and significantly decreased
ROS production in H2O2 treated cells, thus protecting cells from H2O2 induced oxidative
damage. Therefore, we anticipate that our H2S-fibers could be potentially used in
cardiovascular tissue engineering and a broad range of other biomedical applications.
4.4 EXPERIMENTS
4.4.1 Electrospinning of H2S-releasing Fibers
Poly(ε-caprolactone) (PCL) (Average Mn ca. 70-90 kDa, Sigma) were dissolved in
1,1,1,3,3,3-hexafluro-2-propanol (HFIP) (Sigma Aldrich) to obtain 1 to 12% w/w
solutions. For samples containing dopant, the polymer was dissolved in HFIP first,
followed by the addition of NSHD1. Each polymer solution was drawn into fibers by a
home-made electrospinning system described before.51 Briefly, the polymer solution was
transferred to a 1.0 mL plastic syringe (BD) with a 21 G blunt needle (BD precision glide).
A syringe driver was used to control the solution flow rate at 15 μL min-1. A high voltage
supply (HVR Orlando, FL) was used to build up a voltage of 6-7 kV electric field between
the needle and the grounded collector. The distance between the collector and needle was
fixed at 10 cm. The temperature of the electrospinning environment was 25 ºC, and the
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humidity was below 1%. The random fibers were obtained by using a stationary collector.
And the aligned fibers were obtained by using a rotating drum (12 cm in diameter) as the
collector. The rotating rate was 1000 revolutions per minute.
4.4.2 Fiber Analysis
The morphology of PCL fibrous scaffolds and elemental analysis via EDX were
examined by a scanning electron microscopy (SEM, Zeiss Ultra Plus FESEM). Fibrous
scaffolds samples were dried with nitrogen, and coated with gold for 40 seconds with Desk
II cold sputter coater (Denton Vacuum, Morristown, NJ). To examine the uniformity of the
fibrous diameters, several randomly selected areas were imaged. The same condition was
used for EDX. Fibrous diameters were measured using ImageJ (National Institutes of
Health). Fourier transform infrared spectrometry (FTIR) was conducted on a Shimadzu
8400 FTIR spectrometer in the range of 500-4000 cm-1.
4.4.3 Hydrogen Sulfide Release
Reactions for the measurement of H2S release kinetics were run in triplicate. In
each test, 50 mg fibers samples were immersed in 50 mL PBS (pH 7.4). Reaction aliquots
(1.0 mL) were taken to UV-Vis cuvettes containing zinc acetate (100 µL, 1% w/v in H2O),
FeCl3 (200 µL, 30 mM in 1.2 M HCl), and N,N-dimethyl-1,4-phenylenediamine sulfate
(200 µL, 20 mM in 7.2 M HCl) at predetermined time points. Absorbance at 670 nm was
measured 20 min thereafter. H2S concentrations were calculated according to the Na2S
standard curve. To determine the release half-life, 1% w/v zinc acetate was added to the 50
mL PBS containing 50 mg fibers sample. Then reaction aliquots were taken to UV-Vis
cuvettes containing FeCl3 (200 µL, 30 mM in 1.2 M HCl), and N,N-dimethyl-1,4phenylenediamine sulfate (200 µL, 20 mM in 7.2 M HCl) at predetermined time points.
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First-order half-life of H2S release was determined by plotting time vs. ln(1/(1-% released),
with t1/2 = ln(2)/slope.
4.4.5 Cell Lines and Cell Cultures
The rat cardiomyocyte cell line H9c2 and the immortalized mouse fibroblast cell
line NIH 3T3 were purchased from American Type Culture Collection. Both cell lines were
maintained in Dulbecco’s modified Eagle’s medium (DMEM, #D6046, Sigma–Aldrich)
supplemented with 10% heat inactivated fetal bovine serum (Hyclone, Thermo Scientific),
100 U mL-1 penicillin and 100 μg mL-1 streptomycin (Gibco BRL, Invitrogen Corp.,
Carlsbad, CA, USA). Cells were cultured in a 5% CO2 humidified incubator at 37 °C.
Sterilized PCL fibrous scaffolds were soaked in media 30 min prior cell seeding. Cells in
exponential growth phase were trypsinized by 0.25% trypsin and seeded on PCL fibrous
scaffold at a density of 5.2 × 103 cells per cm2.
4.4.6 Cell Viability Assay
Cells growing exponentially were trypsinized and seeded in fibrous scaffolds in
triplicate wells. After 24 hours, the cell viability was analyzed by CellTiter-BlueTM Cell
Viability Assay (Promega, Madison, WI). The CellTiter-Blue reagent was added to the
medium directly (100 μL per 1 mL medium) and incubated for four hours at 37°C.
Fluorescence at 560ex/590em nm filter setting was measured using a Tecan infinite M200
plate reader (Tecan, Salzburg, Austria). After correction of background fluorescence, the
intensity of fluorescence for each sample was normalized by the control. For the
assessment of protective effects of H2S-fibers against oxidative damage, cells were seeded
on fibrous scaffolds with medium containing 250 μM L-Cysteine for predetermined time
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points, then subjected to 400 μM H2O2 treatment for 24 hours. After this, CellTiter-Blue
was applied to determine the cell viability.
4.4.7 Fluorescence Microscopy
Cells growing exponentially were trypsinized and seeded in fibrous scaffolds. At
predetermined time points, cells were rinsed with phosphate buffered saline (PBS) twice
and fixed with 4% paraformaldehyde for 20 min at room temperature. Scaffolds with cells
were rinsed with PBS. Cells were permeabilized with 0.2% Triton X100 for 10 min. To
prevent non-specific labeling, 3% bovine serum albumin (BSA) in PBS were applied as a
blocking buffer for 20 min. Actin cytoskeleton was stained with Rhodamine Phalloidin
(Cytoskeleton Inc.) (1:200) in a blocking buffer for 20 min, and nuclei were stained with
4’,6-diamidino-2-phenylindole (DAPI) (Invitrogen) in a blocking buffer for 10 min. The
fluorescence was visualized and captured under confocal microscope (Olympus IX81) with
DAPI filter and Cy3 filter set.
4.4.8 Detection of H2S in Cells
H9c2 and NIH 3T3 cells were seeded on fibrous scaffolds for 12 hours. The cells
were then incubated with a H2S probe (WSP-5)44 solution (250 μM in PBS) and surfactant
CTAB (500 μM) in PBS at 37 °C for 30 min. After the PBS was removed, the fluorescence
signal was observed by confocal microscope (Olympus IX81) with Cy5 filter.
4.4.9 Reactive Oxygen Species Detection
H9c2 cells were seeded in fibrous scaffolds for 24 hours, then treated with 400 μM
H2O2 for 2 hours. Dihydroethidium (DHE, Invitrogen) staining was applied to quantify
ROS production. Cells were incubated with 10 μM DHE for 30 min at 37 °C. Images were
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obtained using confocal microscope (Olympus IX81) with Cy3 filter. The fluorescent
intensity of the nuclei was measured in each field by ImageJ.
4.4.10 Statistical analysis:
All assays were performed in triplicates unless otherwise stated. Data are indicated
as mean ±SEM. Comparisons were done using one-way ANOVA unless otherwise stated.
All the statistical analyses were done by GraphPad Prism.
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